Optimizing Definitive Endoderm Differentiation in Gastruloids: A Comprehensive Protocol for Robust Modeling and Biomedical Applications

Abstract

This article provides a comprehensive guide for researchers and drug development professionals on the specification and optimization of definitive endoderm (DE) in gastruloids, a key in vitro model for early human development. We cover the foundational biology of endoderm formation, including cellular mechanisms like E-cadherin dynamics and cell size reduction. We then detail optimized differentiation protocols, incorporating recent advances such as retinoic acid pulsing and hypertonic pressure. A major focus is placed on troubleshooting the common challenge of variability, offering strategies to enhance reproducibility. Finally, we evaluate the validation of endoderm-like regions and compare gastruloid models to other systems, establishing their utility for studying developmental biology and screening therapeutic compounds.

Understanding Definitive Endoderm: Principles and Cellular Dynamics in Gastruloid Development

The definitive endoderm (DE) is one of the three primary germ layers formed during mammalian gastrulation and serves as the progenitor tissue for the majority of internal organ systems [1]. This embryonic layer gives rise to the epithelial components of the respiratory and gastrointestinal tracts, along with associated vital organs including the thyroid, liver, pancreas, and bladder [1] [2]. The proper development of DE-derived structures is essential for fundamental physiological processes such as nutrient absorption, gas exchange, detoxification, and glucose homeostasis [1]. In recent years, studies of DE development have been revolutionized by the emergence of gastruloid model systems—three-dimensional aggregates of embryonic stem cells that recapitulate key aspects of gastrulating embryos [3]. These innovative models provide an unparalleled opportunity to study normal and pathological embryogenesis from a bottom-up perspective, offering insights into the cellular behaviors and molecular mechanisms driving endoderm formation [4] [3].

The study of DE development presents unique challenges compared to other germ layers. Historically, investigations were hindered by the endoderm's internal location within the embryo, difficulties in visualization during normal and perturbed development, and its relatively small contribution to the total cell mass—comprising only approximately 3.5% of all cells in the mouse embryo-proper at midgestation [1]. Furthermore, in amniotes, the squamous epithelial nature of nascent endoderm epithelium makes gene expression challenging to localize via traditional mRNA in situ hybridization techniques [1]. Recent advances in molecular marker identification, coupled with high-resolution time-lapse and deep-tissue imaging, have yielded a wealth of new data indicating that although endoderm organs vary in form and function across species, they share conserved mechanisms orchestrating their earliest developmental stages [1].

Embryonic origin and developmental trajectory of the definitive endoderm

Germ layer specification and differentiation

The body plans of bilaterians are triploblastic, deriving from three definitive germ layers: ectoderm (outside), mesoderm (middle), and endoderm (inside) [1]. The mesoderm is thought to have arisen evolutionarily as a derivative of the endoderm approximately 40 million years after the emergence of endoderm and ectoderm, with this diversification credited as the main driver for increased biological complexity in bilaterians [1]. During embryonic development, DE cells are initially internalized during gastrulation but subsequently emerge on the surface of the embryo-proper, forming a sheet of cells that is later re-internalized to form the gut tube and its derivatives [1].

Mammalian embryonic development displays unique features not observed in other organisms, with endoderm cells found in both the embryo-proper and extra-embryonic tissues [1]. Cells with endodermal identity arise at two distinct times during mammalian development: (1) extra-embryonic endoderm (primitive endoderm) arises in the preimplantation embryo from inner cell mass cells, and (2) embryonic endoderm (definitive endoderm) is specified from the pluripotent epiblast at gastrulation [1]. While primitive endoderm predominantly gives rise to yolk sac endoderm layers crucial for nutrient transport, definitive endoderm generates the gut tube running the anterior-posterior length of the embryo, from which endodermal organs bud off [1].

Recent research has revealed that the segregation between embryonic and extra-embryonic endoderm lineages is not absolute. Studies demonstrate that cells derived from the visceral endoderm adjacent to the developing epiblast contribute cellular descendants to the embryonic gut tube, with definitive endoderm cells intercalating with visceral endoderm cells to collectively give rise to the embryonic gut endoderm [1]. Descendants of extra-embryonic visceral endoderm comprise approximately 15% of the gut tube at midgestation, indicating a previously underappreciated developmental contribution [1].

Morphogenetic processes in endoderm formation

Endoderm morphogenesis involves a series of tightly coordinated and precisely timed cellular processes, including epithelial-to-mesenchymal transitions (EMTs), collective cell migration, and mesenchymal-to-epithelial transitions (METs) [1]. Surprisingly, recent observations in both mammalian embryos and gastruloids have challenged the long-standing notion that definitive endoderm formation requires a complete EMT. Instead, evidence suggests that a subset of cells maintains epithelial characteristics while surrounded by cells undergoing changes in E-cadherin expression and cell cohesion [4].

In gastruloid models, endoderm formation follows a three-step mechanism: (1) loss of E-cadherin mediated contacts in parts of the aggregate leading to islands of E-cadherin-expressing cells surrounded by cells devoid of E-cadherin; (2) separation of these two populations with islands of E-cadherin-expressing cells flowing toward the aggregate tip; and (3) differentiation of these cellular aggregates into endoderm populations [4]. This process occurs alongside the expression of T-Brachyury in surrounding cells, reminiscent of events at the primitive streak during embryonic development [4].

Table 1: Key Markers for Definitive Endoderm Identification

Marker	Expression Pattern	Function	Detection Methods
Sox17	Definitive endoderm, visceral endoderm	Transcription factor critical for endoderm development	Immunofluorescence, FACS using Sox17-eGFP reporters [4] [5]
FoxA2	Definitive endoderm, notochord	Transcription factor, pioneer chromatin opener	Immunofluorescence, Western blot [6] [7]
CXCR4	Definitive endoderm cell surface	Chemokine receptor used for purification	FACS, immunocytochemistry [7] [5]
GATA4	Definitive endoderm, heart	Transcription factor	Immunofluorescence [6]
GATA6	Definitive endoderm, primitive endoderm	Transcription factor	Immunofluorescence [6]
E-cadherin	Epithelial cells, endoderm precursors	Cell adhesion molecule	Immunofluorescence, live imaging [4]

Signaling pathways governing definitive endoderm specification

The formation of definitive endoderm is orchestrated by a complex interplay of conserved signaling pathways that direct cell fate decisions and morphogenetic movements. These pathways include Wnt, Nodal/Activin, bone morphogenetic protein (BMP), fibroblast growth factor (FGF), and retinoic acid (RA) signaling [5]. Understanding the precise timing, concentration, and combination of these signals is essential for recapitulating endoderm development both in vivo and in vitro.

The Wnt/β-catenin pathway plays a crucial role in the initial specification of the endodermal lineage, particularly during the primitive streak stages in mammalian embryos. Meanwhile, Nodal/Activin signaling through SMAD2/3 activation is indispensable for endoderm specification and represents the most commonly utilized pathway for in vitro differentiation of pluripotent stem cells to definitive endoderm [5]. The combination of Wnt and Activin A exposure has become a standard approach for generating endoderm-like cells from both mouse and human pluripotent stem cells [5].

Following initial specification, FGF and BMP signaling pathways participate in patterning the endoderm along the anterior-posterior axis, while retinoic acid signaling plays a particularly important role in anterior endoderm patterning and organ specification [8]. The coordinated activity of these pathways ensures proper regional identity within the endodermal germ layer, ultimately giving rise to foregut, midgut, and hindgut structures that generate distinct organ systems.

Figure 1: Signaling pathways regulating definitive endoderm specification from pluripotent stem cells. Multiple signaling pathways coordinate to drive differentiation and establish characteristic molecular markers.

Gastruloids as model systems for studying endoderm development

Fundamentals of gastruloid technology

Gastruloids are three-dimensional aggregates of embryonic stem cells that recapitulate the spatial and genetic composition of gastrulating embryos [9]. These innovative model systems exhibit collective behaviors akin to those observed during early embryonic development, including symmetry breaking and axis elongation [9] [3]. Unlike traditional two-dimensional culture systems, gastruloids more faithfully reproduce the complex cell-cell interactions, signaling gradients, and morphogenetic processes that characterize embryonic development.

The formation of gastruloids typically begins with the aggregation of embryonic stem cells in low-adhesion plates, followed by exposure to specific patterning signals that mimic those present during embryonic gastrulation [4] [3]. Recent improvements in gastruloid technology have resulted in more complex models that generate brain, somite, neural tube, gut tube, and beating heart-like structures in vitro [3]. This increasing complexity has extended to the first human versions of the 3D gastruloid system, opening new avenues for studying human development and disease [3].

One of the key advantages of gastruloids is their tractable nature and the relative ease with which they can be generated in large numbers, providing an unparalleled opportunity to study normal and pathological embryogenesis in a high-throughput manner [3]. This scalability makes them particularly valuable for screening applications and statistical analysis of developmental processes.

Endoderm formation in gastruloid models

In gastruloid models, definitive endoderm formation displays remarkable parallels to embryonic development while also exhibiting some unique characteristics. Studies of mouse gastruloids have revealed that an endoderm-like region is established from a distinct pool of cells different from the mesoderm, with tissue-scale flow localizing the progenitors at a pole [4]. This process involves a heterogeneity of cellular junction tension that could be responsible for segregating the endoderm-like region from the rest of the aggregate via a cell-sorting mechanism [4].

When gastruloids are exposed to Wnt activation via CHIR99021 (a GSK-3β inhibitor), they lose their spherical morphology and acquire a teardrop shape, with a distinct pole of E-cadherin expression emerging at the tip [4]. Time-lapse imaging has demonstrated that E-cadherin and T-Brachyury polarize prior to the onset of tip formation, suggesting a possible role in shape polarization [4]. This polarized group of E-cadherin-expressing cells becomes spatially segregated from and surrounded by T-Brachyury-expressing cells, eventually differentiating into endoderm populations expressing characteristic markers including Sox17 and FoxA2 [4].

Table 2: Comparison of Definitive Endoderm in Different Model Systems

Characteristic	Mouse Embryo	Gastruloid Model	2D hPSC Differentiation
Origin	Epiblast at primitive streak [1]	mESCs forming polarized aggregates [4]	hPSCs in monolayer culture [6]
Key Morphogenetic Processes	EMT, collective migration, MET [1]	E-cadherin dynamics, cell sorting, tissue flows [4]	Limited morphogenesis, primarily molecular differentiation
Spatial Organization	Anterior-posterior patterned gut tube [1]	Polarized E-cadherin+ region at tip [4]	No inherent spatial patterning
Timeline	E6.5-E8.5 in mouse [1]	4-5 days in culture [4]	2-3 days for initial specification [6] [7]
Characteristic Markers	Sox17, FoxA2, CXCR4 [5]	Sox17, FoxA2, E-cadherin [4]	Sox17, FoxA2, CXCR4, GATA4/6 [6]
Applications	Developmental genetics, lineage tracing	High-throughput screening, live imaging [3]	Disease modeling, drug screening, regenerative medicine [6]

Experimental protocols for definitive endoderm differentiation

3D gastruloid protocol for endoderm formation

The following protocol details the generation of gastruloids with definitive endoderm regions from mouse embryonic stem cells (mESCs), based on established methodologies [4]:

Pre-differentiation culture conditions: Maintain mESCs in a pluripotent, post-implantation epiblast-like state by culture in Activin and FGF throughout the pre-differentiation period. This helps prime the cells for subsequent endoderm differentiation.

Aggregation phase:

• Harvest mESCs and resuspend in appropriate aggregation medium.
• Plate cells in 96-well U-bottom low-adhesion plates at a density of 300-500 cells per well.
• Centrifuge plates at 300 × g for 5 minutes to promote aggregate formation.
• Culture for 48 hours to allow formation of compact, spherical aggregates.

Differentiation induction:

• At day 2, expose aggregates to the Wnt agonist CHIR99021 (typically 3-6 μM) in differentiation medium.
• Maintain the CHIR99021 pulse for 24 hours to induce polarization and endoderm specification.
• Replace medium with CHIR99021-free differentiation medium containing Activin A (50 ng/mL) and FGF2 (20 ng/mL).
• Culture for an additional 2-3 days, monitoring for the emergence of polarized morphology.

Key observations:

• By day 4, approximately 80% of aggregates should exhibit elongated, teardrop morphology.
• A distinct pole of E-cadherin expression should be visible at the tip of elongated aggregates.
• This E-cadherin-positive region should co-express endoderm markers Sox17 and FoxA2 by day 4-5.

Quality control:

• Assess aggregate morphology daily using brightfield microscopy.
• Confirm endoderm formation via immunofluorescence for Sox17, FoxA2, and E-cadherin.
• Quantify efficiency of endoderm formation by flow cytometry for CXCR4 and Sox17 expression.

Figure 2: Experimental workflow for generating definitive endoderm in 3D gastruloids. The protocol involves sequential steps from mESC aggregation to polarized endoderm formation through timed signaling activation.

2D monolayer protocol for definitive endoderm differentiation

For applications requiring high efficiency and scalability, 2D monolayer differentiation of human pluripotent stem cells (hPSCs) to definitive endoderm offers a robust alternative [6]:

Pre-differentiation culture:

• Maintain hPSCs in feeder-free conditions using defined medium such as Essential 8 or mTeSR on suitable matrices (Matrigel, Vitronectin, or Synthemax).
• Culture cells to 80-90% confluence prior to differentiation initiation.

Definitive endoderm differentiation:

• Day 0: Aspirate maintenance medium and add Definitive Endoderm Induction Medium A containing CHIR99021 (3 μM) and Vitamin C (71 μg/mL) in DMEM/F12 base medium [6].
• Day 1: Aspirate Medium A and replace with Definitive Endoderm Induction Medium B containing Vitamin C but lacking CHIR99021 [6] [7].
• Day 2: Assess differentiation efficiency via immunostaining or flow cytometry for definitive endoderm markers.

Alternative commercial systems:

• The Gibco PSC Definitive Endoderm Induction Kit follows a similar timeline using proprietary Medium A and Medium B, producing definitive endoderm in 48 hours with ≥90% efficiency across multiple hPSC lines [7].
• The STEMdiff Definitive Endoderm Differentiation Kit provides a defined, animal component-free system for hPSC differentiation to definitive endoderm [10].

Quality assessment:

• Flow cytometry: Analyze for co-expression of CXCR4 and PDGFRα- with target of ≥90% CXCR4+/PDGFRα- population [7] [5].
• Immunocytochemistry: Confirm nuclear expression of Sox17 and FoxA2 with concurrent loss of pluripotency marker Oct4 [7].
• qRT-PCR: Verify upregulation of endoderm genes (SOX17, FOXA2, CXCR4) and downregulation of pluripotency genes (OCT4, NANOG).

Successful differentiation and maintenance of definitive endoderm requires careful selection of appropriate reagents and culture systems. The following table details essential components for definitive endoderm research:

Table 3: Essential Research Reagents for Definitive Endoderm Studies

Reagent Category	Specific Examples	Function/Application	Notes
Basal Media	DMEM/F12, RPMI, SFEM/IMDM [6] [5]	Base formulation for differentiation media	Component consistency is critical for reproducibility
Signaling Molecules	CHIR99021 (Wnt activator), Activin A (Nodal mimic), FGF1/FGF4, BMP4, Retinoic Acid [6] [5]	Direct cell fate toward definitive endoderm	Concentration and timing are protocol-dependent
Extracellular Matrices	Matrigel, Vitronectin XF, Synthemax II-SC [10] [6]	Substrate for hPSC maintenance and differentiation	Batch-to-batch variability can affect outcomes
Cell Dissociation Reagents	Accutase, Gentle Cell Dissociation Reagent [10] [6]	Passage and harvesting of cells	Enzyme-free options improve cell viability
Small Molecule Inhibitors	LDN193189 (BMP inhibitor), Y-27632 (ROCK inhibitor) [6]	Enhance cell survival and direct differentiation	Y-27632 particularly useful during passaging
Characterization Antibodies	Anti-Sox17, Anti-FoxA2, Anti-GATA4/6, Anti-CXCR4 [6] [7]	Identification and purification of definitive endoderm	Validation for flow cytometry vs. immunofluorescence needed
Commercial Kits	STEMdiff Definitive Endoderm Kit, Gibco PSC Definitive Endoderm Induction Kit [10] [7]	Standardized definitive endoderm differentiation	Reduce protocol variability between labs

Optimization strategies and troubleshooting

Addressing variability in gastruloid systems

Gastruloid systems are prone to variability at multiple levels, which can impact the reproducibility and reliability of experimental outcomes [9]. This variability can be attributed to both intrinsic factors (stem cell heterogeneity, stochastic differentiation) and extrinsic factors (culture conditions, environmental cues) [9]. Several strategies can be employed to minimize this variability:

Pre-aggregation control:

• Implement precise cell counting and standardized aggregation methods to ensure consistent initial aggregate size and composition.
• Utilize microwell arrays or hanging drop techniques to improve uniformity in aggregate formation.
• Consider higher starting cell numbers to reduce sampling bias, though this must be balanced against biological optimality.

Culture condition standardization:

• Minimize batch-to-batch variation in media components by using defined, serum-free formulations.
• Control for passage number effects by using cells within a defined passage range post-thaw.
• Standardize pre-growth conditions to ensure consistent pluripotency states prior to differentiation.

Process monitoring and intervention:

• Employ live imaging to track gastruloid development and identify early parameters predictive of successful endoderm formation.
• Implement personalized interventions by adjusting protocol timing based on individual gastruloid development rather than fixed timelines.
• Utilize machine learning approaches to identify key morphological parameters that correlate with successful endoderm differentiation [9].

Enhancing endoderm differentiation efficiency

Several challenges commonly arise in definitive endoderm differentiation protocols, with corresponding solutions:

Low differentiation efficiency:

• Problem: Inconsistent or low expression of Sox17/FoxA2.
• Solutions: Optimize CHIR99021 concentration (typically 3-6 μM); ensure proper cell density at initiation (80-90% confluence); verify Activin A bioactivity.
• Validation: Use multiple markers (Sox17, FoxA2, CXCR4) for comprehensive assessment.

Incomplete pluripotency exit:

• Problem: Persistent Oct4 expression alongside endoderm markers.
• Solutions: Extend differentiation duration; optimize CHIR99021 pulse length; include BMP inhibition during initial stages if appropriate for specific cell lines.
• Validation: Monitor downregulation of pluripotency markers via qRT-PCR or immunostaining.

High cell death during differentiation:

• Problem: Significant cell detachment and death, particularly in 2D cultures.
• Solutions: Include ROCK inhibitor (Y-27632) during passage and initial differentiation; optimize extracellular matrix coating; ensure gradual media changes to minimize shock.
• Validation: Quantify viability using dye exclusion methods or metabolic assays.

Future directions and applications

The field of definitive endoderm research continues to evolve rapidly, with several promising directions emerging. Gastruloid technology is progressing toward increased complexity, with recent models incorporating brain, somite, neural tube, gut tube, and even beating cardiac structures [3]. These advances provide unprecedented opportunities to study endoderm-organ interactions in vitro.

In the realm of disease modeling, definitive endoderm differentiation protocols enable the generation of patient-specific organoids for conditions affecting endoderm-derived tissues, including pancreatic disorders, liver diseases, and intestinal pathologies [6]. The scalability of gastruloid systems makes them particularly amenable to high-throughput drug screening approaches, potentially accelerating the discovery of therapeutics for endoderm-related diseases.

From a technical perspective, future improvements will likely focus on enhancing reproducibility through standardized protocols and quality control measures [9]. The development of more sophisticated bioreactor systems and automated imaging platforms will further increase the utility of gastruloids for large-scale studies. Additionally, the integration of multi-omics approaches—including single-cell RNA sequencing, spatial transcriptomics, and epigenomic profiling—with gastruloid technology promises to provide unprecedented resolution of the molecular events governing endoderm development [9].

As these models continue to advance, they will undoubtedly yield new insights into the fundamental biology of endoderm development while simultaneously providing powerful platforms for pharmaceutical development and regenerative medicine applications.

Definitive endoderm (DE) is one of the three primary germ layers formed during gastrulation, serving as the embryonic precursor to the epithelial components of vital organs including the liver, pancreas, lungs, thyroid, and the entire gastrointestinal tract [5] [11]. The accurate identification and purification of DE cells through specific molecular markers is therefore a critical prerequisite for developmental biology studies, disease modeling, drug screening, and regenerative medicine applications [6] [12]. Within the emerging field of gastruloid research—which utilizes stem cell-derived, self-organizing aggregates to model embryonic development—precise DE characterization becomes even more crucial due to the inherent morphogenetic variability of these in vitro systems [13] [14]. This application note details the core and emerging molecular markers for DE identification and provides standardized protocols for their detection, specifically framed within the context of gastruloid differentiation research.

Core Marker Panel for Definitive Endoderm Identification

The core transcriptional machinery driving DE specification centers around a well-defined set of transcription factors. The markers SOX17 and FOXA2 constitute the minimal essential panel for definitive identification, while additional markers provide confirmation and contextual information about the differentiation stage and purity.

Table 1: Core Molecular Markers for Definitive Endoderm Identification

Marker	Marker Type	Expression & Function	Detection Notes
SOX17	Transcription Factor (High-Mobility Group box)	Key specifier of DE fate; regulates gut tube morphogenesis [15] [5]	Nuclear localization; ≥90% expression indicates high-purity differentiation [7]
FOXA2	Transcription Factor (Forkhead box)	Pioneer factor that opens chromatin; regulates DE development [16] [11]	Nuclear localization; co-expression with SOX17 is definitive for DE [7] [16]
CXCR4	Chemokine Receptor	Cell surface marker; expressed in nascent DE cells [17] [5]	Cell membrane; used for FACS purification (typically CXCR4+/PDGFRα-) [7] [5]
GATA6	Transcription Factor (Zinc-finger)	Binds and activates endodermal genes; cooperates with SMAD2/3 [15] [11]	Nuclear localization; positively correlated with DE differentiation efficiency [15] [6]

The co-expression of SOX17 and FOXA2 is a gold-standard indicator for DE. A differentiation protocol can be considered highly efficient when these markers are expressed in ≥90% of the cell population [7]. It is critical to note that SOX17 is also expressed in extraembryonic visceral endoderm (VE). Therefore, reliance on SOX17 alone is insufficient for definitive identification; confirmation with FOXA2, a marker not expressed in VE, is necessary to distinguish DE from extraembryonic lineages [5].

Beyond the Core Panel: Key Regulatory Markers

Several other markers play crucial roles in the regulatory cascade leading to DE formation. While they may not be used in isolation for identification, their presence confirms a correctly patterned differentiation.

• EOMES and MIXL1: These are mesendodermal markers expressed transiently in the primitive streak prior to DE specification. They are indicators of successful exit from pluripotency and entry into the correct developmental trajectory [12] [17].
• GATA4: A transcription factor involved in the development of DE-derived organs. It is often used alongside GATA6 for confirming DE identity [6].
• CER1 and LEFTY1: These are markers of the anterior visceral endoderm (AVE) and anterior DE. Their expression can indicate regional patterning within a DE population [17] [5].

Experimental Protocols for Marker Analysis

Standardized Protocol for Definitive Endoderm Differentiation from hPSCs

The following protocol, adapted from a 2025 publication, provides a chemically-defined, efficient system for generating DE from human pluripotent stem cells (hPSCs) [6]. This protocol serves as a foundational method for generating cells for marker analysis.

Key Resources Table

REAGENT or RESOURCE	SOURCE	IDENTIFIER
Antibodies
FoxA2/HNF3β (D56D6) XP rabbit mAb	Cell Signaling Technology	Cat#:8186
Human SOX17 antibody	R&D Systems	Cat#AF1924
Goat anti-rabbit IgG (H+L), Alexa Fluor 488	Thermo Fisher Scientific	Cat#A11008
DAPI	Sigma	Cat#D9542
Chemicals & Cell Lines
TeSR-E8 kit	STEMCELL Technologies	05990
Matrigel	BD Biosciences	354277
CHIR99021	Selleck	S2924
Accutase	STEMCELL Technologies	07920
Human ESC line H1 or H9	WiCell	N/A

Day 0: Seeding hPSCs

• Culture hPSCs on Matrigel-coated plates in TeSR-E8 medium until they reach 80-90% confluence.
• Dissociate cells using Accutase and neutralize with DMEM/F12.
• Seed the cells at an appropriate density (e.g., 200,000 cells/cm²) in TeSR-E8 medium supplemented with 10 µM Y-27632 (ROCK inhibitor) to enhance survival.
• Incubate cells at 37°C with 5% CO₂.

Day 1: Induction to Primitive Streak/Mesendoderm

• Replace medium with pre-warmed Definitive Endoderm Induction Medium A, consisting of DMEM/F12, 3 µM CHIR99021 (a WNT pathway activator), and 71 µg/mL Vitamin C [6].
• Incubate for 24 hours.

Day 2: Induction to Definitive Endoderm

• Aspirate Medium A and replace with pre-warmed Definitive Endoderm Induction Medium B. The exact composition of Medium B is proprietary in some commercial kits [7], but it typically contains growth factors like Activin A to activate Nodal/TGF-β signaling, which is crucial for DE specification [11].
• Incubate for 24 hours.

Day 3: Analysis

• Cells can be harvested on Day 3 for analysis. High-quality DE differentiation should show ≥90% of cells co-expressing SOX17 and FOXA2, with a corresponding downregulation of pluripotency markers like OCT4 [7].

Immunofluorescence Staining and Analysis for Key Markers

This protocol details the steps for validating DE formation through the detection of core protein markers.

Fixation and Permeabilization

• Aspirate culture medium and wash cells once with phosphate-buffered saline (PBS).
• Fix cells with 4% Paraformaldehyde (PFA) for 15 minutes at room temperature.
• Remove PFA and wash cells three times with PBS, 5 minutes per wash.
• Permeabilize and block by incubating cells in a solution of PBS containing 0.1% Triton X-100 and 1% Bovine Serum Albumin (BSA) for 45 minutes at room temperature.

Antibody Staining

• Prepare primary antibodies diluted in PBS with 1% BSA. Recommended dilutions: anti-SOX17 (1:200), anti-FOXA2 (1:200), anti-GATA6 (1:200) [6].
• Apply primary antibody solution to the fixed cells and incubate overnight at 4°C.
• Remove primary antibody and wash three times with PBS, 5 minutes per wash.
• Prepare secondary antibodies conjugated to fluorophores (e.g., Alexa Fluor 488, 555, 647) diluted 1:300 in PBS with 1% BSA.
• Apply secondary antibody solution and incubate for 1 hour at room temperature, protected from light.
• Remove secondary antibody and wash three times with PBS, 5 minutes per wash.
• Counterstain nuclei with DAPI (1 µg/mL) for 5 minutes.
• Acquire images using a confocal microscope (e.g., Zeiss LSM780). Co-localization of SOX17 and FOXA2 in the nucleus confirms DE identity.

Flow Cytometry for Quantification of DE Purity

For quantitative assessment of differentiation efficiency, flow cytometry is the preferred method.

• Harvest DE cells on Day 3 using Accutase to create a single-cell suspension.
• Wash cells once in FACS buffer (PBS + 2% FBS).
• Stain cells with antibodies against the surface marker CXCR4 (e.g., APC-conjugated anti-CXCR4) for 30 minutes on ice, protected from light. A PDGFRα antibody can be used in tandem to exclude mesodermal progenitors (defining the population as CXCR4+/PDGFRα-) [7] [5].
• Wash cells twice with FACS buffer to remove unbound antibody.
• Analyze cells using a flow cytometer (e.g., CytoFLEX-S). A successful differentiation typically yields a population with ≥90% CXCR4+ cells [7].

Signaling Pathways and Novel Regulators in DE Specification

The differentiation of pluripotent stem cells to DE is orchestrated by key signaling pathways. The following diagram illustrates the core signaling network and its integration with novel regulatory layers.

The core signaling is initiated by WNT and Nodal/Activin A [11]. This leads to the phosphorylation of SMAD2/3, which translocates to the nucleus and, in cooperation with transcription factors like EOMES, directly activates the expression of SOX17, FOXA2, and GATA6 [15] [11]. The pluripotency factor NANOG also plays a dual role, initially repressing differentiation genes and later promoting the expression of EOMES to facilitate the transition to DE [11].

Beyond these canonical pathways, recent research has highlighted the importance of several novel regulatory layers in gastruloid and DE biology:

• Long Non-Coding RNAs (lncRNAs): LncRNAs such as GATA6-AS1 regulate DE differentiation by interacting with SMAD2/3 and promoting its binding to the promoter of GATA6, thereby enhancing the expression of key endodermal genes [15].
• Metabolic and Epigenetic Regulation: DE differentiation involves a metabolic switch from glycolysis to oxidative phosphorylation [11]. This shift alters metabolite pools (e.g., acetyl-CoA, SAM, α-KG) that serve as substrates and cofactors for epigenetic modifications, thereby remodeling chromatin and enabling the expression of endodermal genes like FOXA2 [11].
• Endoplasmic Reticulum (ER) Stress: The unfolded protein response (UPR) is upregulated during DE differentiation. Inhibition of the Sigma-1 receptor (a chaperone that attenuates ER stress) can increase the expression of the DE marker SOX17, suggesting that induction of ER stress may enhance DE differentiation efficiency [12].

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Research Reagents for Definitive Endoderm Studies

Reagent / Kit	Primary Function	Application Note
Gibco PSC Definitive Endoderm Induction Kit [7]	Directed differentiation of hPSCs to DE	A two-medium, 2-day system; enables ≥90% efficiency for SOX17/FOXA2 expression.
TeSR-E8 Medium [6]	Maintenance of hPSCs	Feeder-free, chemically-defined medium for culturing pluripotent stem cells prior to differentiation.
Matrigel / Vitronectin [6]	Extracellular Matrix Coating	Provides a defined substrate for the attachment and growth of hPSCs in feeder-free conditions.
CHIR99021 [6]	Small Molecule GSK-3 Inhibitor	Activates WNT signaling; critical for the initial induction of primitive streak/mesendoderm.
Anti-SOX17 / FOXA2 / CXCR4 Antibodies [6] [7] [5]	Cell Characterization	Essential for immunostaining and flow cytometry to confirm DE identity and purity.
MycoAlert Mycoplasma Detection Kit [6]	Cell Culture Quality Control	Ensures cells are free from mycoplasma contamination, which can alter differentiation outcomes.

The robust identification of definitive endoderm, particularly within complex models like gastruloids, relies on a multifaceted strategy centered on the co-detection of SOX17 and FOXA2. This must be supplemented with the quantification of surface markers like CXCR4 and the downregulation of pluripotency factors. The integration of emerging knowledge on the roles of lncRNAs, metabolism, and ER stress provides a deeper understanding of the regulatory network governing DE formation. The standardized protocols and reagent toolkit outlined in this document provide a foundation for researchers to reliably generate, characterize, and utilize definitive endoderm cells, thereby advancing the fields of developmental biology, drug screening, and regenerative medicine.

This application note explores the critical role of E-cadherin-mediated cell adhesion and coordinated tissue flow in definitive endoderm (DE) formation. Within the context of gastruloid protocol research, emerging evidence demonstrates that endoderm specification does not proceed through a classical epithelial-to-mesenchymal transition (EMT) but rather via a more nuanced mechanism of epithelial cell plasticity [18]. The dynamics of E-cadherin adherens junctions serve as a key regulatory point, integrating mechanical cues from the extracellular microenvironment with intracellular signaling pathways, notably the YAP/TAZ pathway, to direct cell fate decisions [19] [20]. Understanding this cellular choreography is paramount for developing robust, high-efficiency differentiation protocols for generating DE and its derivative tissues for drug screening and regenerative medicine applications.

Quantitative Data on E-cadherin in Endoderm Specification

The following table consolidates key quantitative findings from recent investigations into E-cadherin dynamics during endoderm formation.

Table 1: Quantitative Summary of E-cadherin Roles in Endoderm Formation

Experimental System	Key Finding on E-cadherin	Quantitative/Measured Outcome	Functional Consequence
hESCs on Stiffness-Varied Hydrogels [19]	Negative correlation with differentiation progress and substrate stiffness	E-cadherin expression reduced with progressive differentiation stages; Blocking E-cadherin enhanced DE productivity	Increased YAP nuclear translocation, GATA6 and CXCR4 expression; Stiffness-dependent DE enhancement
Mouse Gastruloids [4]	Loss and re-emergence defines endoderm progenitors	~80% of aggregates formed a distinct E-cadherin-rich pole; Preceded morphological elongation	Segregation and flow of E-cadherin+ cells to aggregate tip; Differentiation into Sox17+/Foxa2+ endoderm
Mouse Embryo & ESCs (in vivo/in vitro) [18]	Maintained in endoderm, not mesoderm	Definitive endoderm progenitors maintained E-cadherin and synchronously upregulated N-cadherin	Endoderm forms via Foxa2-driven EMT-independent pathway (epithelial plasticity), not full EMT-MET cycle
Biomimetic Membrane System [20]	Forms specific adhesive intermediates	Identification of a transient X-dimeric state with an EC5-EC5 distance of ~29 nm	Provides kinetic pathway for stable junction formation (S-dimer: ~37 nm)

Core Experimental Protocols

Modulating E-cadherin Function in hESC Differentiation on Tunable Hydrogels

This protocol is designed to investigate the interplay between substrate mechanics, E-cadherin function, and DE differentiation [19].

Workflow Diagram: E-cadherin & Stiffness in DE Differentiation

Materials:

• Cells: H1 human Embryonic Stem Cells (authorized by WiCell)
• Substrates: Polyacrylamide (PA) hydrogels of defined stiffness (e.g., 0.14 kPa, 6.1 kPa, 46.7 kPa)
• Coating: Rat Collagen I
• Key Reagents:
  • E-cadherin Blocking Antibody: Mouse anti-human E-cadherin (M106, TaKaRa)
  • Control: Appropriate species-matched IgG isotype control
  • DE Induction Base Medium: Chemically defined, insulin/albumin-free medium (e.g., RPMI 1640)
  • Induction Factor: Activin A (100 ng/mL)
  • Small Molecules: CHIR99021 (Wnt activator)
• Analysis Antibodies: Anti-E-cadherin (ab76055, Abcam), anti-YAP (CST #12395), anti-GATA6 (CST #5851), anti-CXCR4 (Abcam ab208128)

Methodology:

• PA Gel Fabrication: Prepare stiffness-varied PA hydrogels using published soft-lithography techniques. Use specific ratios of acrylamide and bis-acrylamide to achieve the desired elastic modulus (e.g., 0.14 kPa: 3%/0.04%, 46.7 kPa: 10%/0.3%). Covalently crosslink collagen I to the gel surface.
• Cell Seeding and Pre-culture: Seed H1 hESCs as small aggregates onto collagen-coated PA gels. Culture in mTeSR1 medium for 2-3 days to re-establish colonies.
• E-cadherin Blocking: Prior to DE induction, incubate cells with the E-cadherin blocking antibody (e.g., 5-10 µg/mL) or isotype control for 4-6 hours.
• DE Differentiation: Initiate differentiation by switching to DE induction base medium supplemented with 100 ng/mL Activin A and 3 µM CHIR99021 for the first day. Continue with Activin A for an additional 2-4 days.
• Analysis:
  • Immunofluorescence: Stain for E-cadherin, YAP, and DE markers (GATA6, CXCR4). Quantify nuclear-to-cytoplasmic YAP ratio.
  • Flow Cytometry: Quantify the percentage of CXCR4-positive cells to assess DE differentiation efficiency.
  • qRT-PCR: Analyze transcript levels of SOX17, FOXA2, and CXCR4.

Live Imaging of Endoderm Morphogenesis in 3D Gastruloids

This protocol enables the observation of E-cadherin dynamics and tissue flow during the de novo formation of an endoderm-like region in mouse gastruloids [4].

Workflow Diagram: Endoderm Formation in Gastruloids

Materials:

• Cells: Mouse Embryonic Stem Cells (mESCs), preferably with knock-in reporters for E-cadherin and T/Brachyury (T-Bra).
• Gastruloid Culture Medium: Based on N2B27 medium, supplemented with relevant cytokines.
• Key Small Molecules & Cytokines:
  • Activin A: To maintain primed epiblast-like state.
  • Fibroblast Growth Factor (FGF): To maintain primed epiblast-like state.
  • CHIR99021 (Chiron): Wnt agonist for pulsed induction.
• Imaging Dishes: Glass-bottom dishes suitable for long-term live-cell imaging.
• Antibodies for Validation: Anti-Sox17, Anti-Foxa2.

Methodology:

• Aggregate Formation: Harvest and resuspend mESCs to an appropriate density. Deposit a defined number of cells (e.g., 300-500) into each well of a U-bottom low-attachment 96-well plate. Centrifuge to form aggregates.
• Pre-patterning: Culture aggregates for 48 hours in N2B27 medium supplemented with Activin A (e.g., 20 ng/mL) and FGF (e.g., 12 ng/mL) to establish a homogeneous, post-implantation epiblast-like state.
• Wnt Pulsing: On day 2, expose aggregates to 3 µM CHIR99021 for 24 hours to induce polarization.
• Live-Cell Imaging: Following the Chiron pulse, transfer gastruloids to an imaging chamber. Acquire time-lapse confocal images every 20-30 minutes for 24-48 hours using appropriate lasers for the fluorescent reporters (E-cadherin, T-Bra).
• Endpoint Analysis: At the conclusion of imaging, fix gastruloids and perform immunofluorescence for definitive endoderm markers (Sox17, Foxa2) to confirm the identity of the E-cadherin-rich region.
• Image Analysis:
  • Track Island Movement: Manually or automatically track the movement of E-cadherin-positive "islands" towards the tip.
  • Quantify Signal Intensity: Measure fluorescence intensity of E-cadherin and T-Bra over time and in different regions of the gastruloid.
  • Analycell Shape & Morphology: Assess cell shape changes, particularly at the interface between E-cadherin-high and E-cadherin-low regions.

Key Signaling Pathways in Endoderm Morphogenesis

The integration of mechanical and biochemical signals is pivotal for guiding endoderm formation. E-cadherin dynamics sit at the crossroads of these pathways.

Signaling Pathway Diagram: E-cadherin in Fate Specification

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents for Investigating E-cadherin in Endoderm Formation

Reagent / Tool	Specific Example (Supplier, Catalog #)	Function in Protocol
Functional Anti-E-cadherin	Mouse anti-human E-cadherin (M106; TaKaRa)	Blocks E-cadherin-mediated adhesion to probe function in differentiation [19].
Stiffness-Tunable Hydrogels	Polyacrylamide Hydrogels (custom synthesis)	Provides defined mechanical microenvironment to study mechanotransduction [19].
DE Induction Small Molecules	CHIR99021 (Selleck, S2924); LDN193189 (Selleck, S7507)	Activates Wnt signaling (CHIR); Inhibits BMP signaling (LDN) to direct DE fate [6] [21].
Critical Cytokines	Activin A (PeproTech); Recombinant Wnt3a (R&D Systems)	Activates Nodal/TGF-β signaling (Activin A); Enhances DE specification [21].
Key Validation Antibodies	Anti-SOX17 (R&D Systems, AF1924); Anti-FOXA2 (CST, #8186); Anti-CXCR4 (BioLegend, 306506)	Definitive markers for identifying and quantifying DE cells via IF/Flow Cytometry [6] [22].
Gastruloid Formation Plates	U-bottom Low-Adherence 96-well Plates (e.g., Corning)	Ensures formation of uniform, single 3D aggregates for reproducible gastruloid culture [4].
Live-Cell Reporter Lines	Foxa2-tagRFP; T-GFP; E-cadherin-GFP knock-in mESCs	Enables real-time, single-cell tracking of lineage specification and adhesion dynamics [4] [18].

---

Within the context of definitive endoderm (DE) differentiation and gastruloid protocol research, recent studies highlight that cell size diminution is not merely a passive consequence but an active regulator of DE specification. Quantitative single-cell analyses reveal that DE differentiation is accompanied by a progressive reduction in cell size, increased stiffness, and enhanced actomyosin activity [23]. This application note integrates these findings into a detailed protocol for leveraging hypertonic pressure and 3D culture systems to enhance the efficiency of DE differentiation from human pluripotent stem cells (hPSCs).

---

Key Quantitative Findings

Table 1: Dynamic Changes in Cell Size and Mechanical Properties During DE Differentiation

Parameter	hPSCs (Baseline)	DE Cells (Differentiated)	Measurement Method
Average Cell Diameter	~15–18 μm	~10–12 μm	Flow cytometry (FSC) [23]
Cell Volume	High	Reduced by ~30–40%	3D confocal imaging [23]
Cell Stiffness (Young’s Modulus)	Low	High	Atomic force microscopy [23]
Actomyosin Activity	Low	High	Immunofluorescence [23]
Nuclear AMOT Localization	Absent	Present	Imaging and functional assays [23]

Table 2: Impact of Spheroid Size on DE Differentiation Efficiency in 3D Cultures

Spheroid Size (Cells/Spheroid)	DE Marker Expression (SOX17/CXCR4)	Morphological Stability	Recommended Culture System
200 cells	Low	Unstable	Suspension [24]
500 cells	Moderate	Moderate	Suspension/NFC hydrogel [24]
1,000 cells	High	High	Suspension [24]

---

Experimental Protocols

Protocol 1: Hypertonic Pressure-Induced DE Differentiation

Objective: To enhance DE specification by accelerating cell size reduction via hypertonic treatment [23].

Materials:

• hPSCs (e.g., H1 or iPS(IMR90)-4 lines).
• Hypertonic medium: RPMI-1640 + 1× B-27 + 100 ng/mL activin A + 50–100 mM sucrose (or NaCl).
• Isotonic control: RPMI-1640 + 1× B-27 + activin A.
• ROCK inhibitor (Y-27632).

Steps:

• Culture hPSCs in mTeSR1 on Matrigel-coated plates until 60–70% confluency.
• Dissociate cells into single cells using Accutase.
• Form spheroids using AggreWell400 (500–1,000 cells/spheroid) in mTeSR1 + 10 μM ROCK inhibitor.
• Induce DE:
  • Transfer spheroids to hypertonic medium.
  • Maintain for 48–72 h with daily medium changes.
• Validate DE markers via flow cytometry (CXCR4⁺/SOX17⁺) and qPCR (FOXA2, SOX17).

Mechanistic Insight: Hypertonic pressure triggers actomyosin contraction, leading to AMOT nuclear translocation and YAP suppression, which promotes DE gene expression [23].

Protocol 2: 3D Suspension Culture for Size-Controlled Spheroids

Objective: To maintain optimal spheroid size and morphology for high-efficiency DE differentiation [24].

Materials:

• Low-attachment plates (e.g., Corning 3474).
• NFC hydrogel (e.g., GrowDex) for comparative assays.
• DE induction medium: RPMI-1640 + 1× B-27 + 100 ng/mL activin A + 10 μM ROCK inhibitor.

Steps:

• Generate spheroids in AggreWell400 (500–1,000 cells/spheroid).
• Transfer spheroids to low-attachment plates or NFC hydrogel (0.55% w/v).
• Culture in DE induction medium for 6 days, replacing medium daily.
• Harvest spheroids: For NFC hydrogel, use cellulase enzyme to recover intact structures [24].
• Assess viability (Live/Dead staining) and differentiation (immunofluorescence for SOX17/FOXA2).

Note: Suspension cultures outperform hydrogel systems in mass transfer and differentiation homogeneity [24].

---

Signaling Pathways and Workflow

Diagram: Mechanical Regulation of DE Specification via Cell Size Diminution

Title: Mechanical Pathway Linking Cell Size to DE Specification

Diagram: Experimental Workflow for 3D DE Differentiation

Title: Workflow for 3D DE Differentiation with Size Control

---

The Scientist’s Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for DE Differentiation Protocols

Reagent	Function	Example Product
Activin A	TGF-β ligand mimicking Nodal signaling	PeproTech 120-14E [24] [25]
CHIR99021	GSK-3 inhibitor for Wnt activation	Stemgent 04-0004 [26]

• ROCK Inhibitor (Y-27632) : Prevents apoptosis in dissociated cells [24].
• NFC Hydrogel (GrowDex) : Xeno-free 3D matrix for spheroid culture [24].
• Fibronectin/Vitronectin : ECM proteins supporting ITGA5/ITGAV-mediated DE differentiation [27].
• CXCR4 Antibody : Surface marker for isolating DE cells [25] [17].

---

Integrating cell size control into DE differentiation protocols significantly enhances efficiency and reproducibility. The combined use of hypertonic pressure, 3D suspension cultures, and size-adjusted spheroids provides a robust framework for generating high-purity DE cells. These strategies are critical for advancing gastruloid-based disease modeling and regenerative medicine applications.

The efficient and reproducible differentiation of pluripotent stem cells into definitive endoderm (DE) is a critical prerequisite for generating tissues for regenerative medicine, disease modeling, and drug discovery [28] [29]. This process mimics embryonic development, where germ layer specification is coordinated by a handful of evolutionarily conserved signaling pathways. Among these, WNT, ACTIVIN/Nodal, and BMP signaling play preeminent roles. In vivo, the definitive endoderm is generated through a complex sequence of cellular events involving cell-state transitions and collective cell movement [4]. The emergence of gastruloids—three-dimensional aggregates of stem cells that recapitulate aspects of the gastrulating embryo—has provided a powerful model system to dissect these signaling interactions [9] [13]. However, these complex models are prone to variability, and a precise understanding of the signaling landscape is necessary to steer differentiation toward robust and reproducible endodermal outcomes [9]. This Application Note delineates the specific roles of WNT, ACTIVIN, and BMP pathways in directing endoderm fate within gastruloid models and provides detailed protocols for their manipulation.

Pathway Functions and Experimental Modulation

The following table summarizes the primary functions of each key signaling pathway in endoderm specification and common methods for their experimental modulation in gastruloid protocols.

Table 1: Key Signaling Pathways in Endoderm Specification and Their Modulation

Signaling Pathway	Primary Role in Endoderm Specification	Common Agonists/Activators	Common Antagonists/Inhibitors
WNT	Initiates primitive streak/mesendoderm formation; induces intestinal master regulator CDX2; posteriorizes endoderm [30] [31].	CHIR99021 (GSK-3β inhibitor) [31]	IWP2, XAV939 (WNT production/response inhibitors)
ACTIVIN/Nodal	Primary driver of mesendoderm and definitive endoderm formation; acts as a morphogen where high levels promote endoderm [29] [31].	Recombinant Activin A, Nodal [29]	SB431542 (ALK4/5/7 inhibitor)
BMP	Specifies ventrolateral endoderm; works in concert with WNT; levels must be precisely tuned [32] [31].	Recombinant BMP4, BMP2, BMP7 [32] [31]	Noggin, Chordin, Dorsomorphin (BMP signaling inhibitors) [32]

Detailed Experimental Protocols for Gastruloid Differentiation

Core Gastruloid Differentiation Workflow

The foundational process for generating gastruloids from pluripotent stem cells involves a series of timed and coordinated steps, as visualized below.

Protocol 1: Generating Definitive Endoderm from hiPSCs

This protocol is adapted from recent studies that emphasize the precise modulation of signaling pathways to achieve robust DE formation [29] [31].

• Pre-differentiation Culture of hiPSCs

  • Cell Line: UCSD167i-99-1 hiPSC or equivalent.
  • Culture Conditions: Maintain hiPSCs in feeder-free conditions on hPSC-qualified Matrigel in mTeSR1 or mTeSR Plus medium.
  • Passaging: Use standard enzymatic or EDTA-based passaging methods. Cells should be maintained in a state of high pluripotency with daily medium changes [31].

• Definitive Endoderm Differentiation (Days 0-4)

  • Day 0: Mesendoderm Induction: Accurately dissociate hiPSCs into a single-cell suspension. Aggregate approximately 3,000 - 5,000 cells per well in a 96-well U-bottom low-attachment plate. The base medium for differentiation is RPMI 1640 supplemented with B-27. The initial differentiation step is crucial for mesendoderm formation.
    • Signaling Modulations:
      • High ACTIVIN Group: Treat with 100 ng/mL recombinant human Activin A.
      • WNT Group: Treat with 3 μM CHIR99021.
      • Control Group: Base medium only.
  • Day 2: Definitive Endoderm Specification: Refresh the medium with fresh RPMI/B-27.
    • Signaling Modulations: Continue 100 ng/mL Activin A. Add 4 ng/mL recombinant human BMP4 to the appropriate conditions to promote DE specification [31].
  • Day 4: Analysis: Harvest gastruloids for analysis. Key definitive endoderm markers to assess include SOX17, FOXA2, and CXCR4 via immunostaining, RT-qPCR, or flow cytometry.

Protocol 2: Optimizing Endoderm Morphogenesis in Mouse Gastruloids

This protocol focuses on reducing variability and achieving specific endodermal morphotypes, leveraging machine learning predictions [13].

• Baseline Mouse Gastruloid Protocol

  • Cells: Mouse Embryonic Stem Cells (mESCs).
  • Aggregation: Aggregate 300-400 mESCs in 96-well U-bottom plates in N2B27 medium.
  • WNT Activation: At 48 hours, add a pulse of the WNT agonist Chiron (CHIR99021, 3 μM) for 24 hours to break symmetry and induce axial elongation [9] [4].

• Interventions for Reducing Variability and Steering Morphotype

  • Improved Seeding Control: Use microwell arrays or hanging drops to ensure highly uniform initial cell counts per aggregate, reducing gastruloid-to-gastruloid variability [9].
  • Pulsed Interventions: Based on live imaging and predictive modeling, apply short, timed pulses of Activin A (e.g., 50-100 ng/mL) or BMP4 (e.g., 4-10 ng/mL) between days 3-4 to boost the frequency of gut-tube formation. This can help resynchronize developmental processes [13].
  • Gastruloid-Specific Interventions: For high-value experiments, track individual gastruloid progression (e.g., elongation, marker expression). Tailor the timing of signaling pathway activation or inhibition to the specific state of each gastruloid, a process known as "personalized interventions" [9].

Pathway Crosstalk and Integrated Signaling Logic

The signaling pathways do not act in isolation but form an integrated network. The following diagram illustrates the logical relationships and critical crosstalk between WNT, ACTIVIN/Nodal, and BMP signaling during the stepwise specification of endoderm.

The Scientist's Toolkit: Essential Research Reagents

A successful definitive endoderm differentiation experiment relies on a core set of validated reagents. The following table details essential materials and their functions.

Table 2: Key Research Reagent Solutions for Definitive Endoderm Differentiation

Reagent Category	Specific Examples	Function in Protocol
Small Molecule Agonists	CHIR99021 [31]	Activates WNT signaling by inhibiting GSK-3β; critical for mesendoderm induction.
Recombinant Growth Factors	Recombinant Human Activin A [29] [31], Recombinant Human BMP4 [32] [31], FGF2 [29]	Activin A is the primary driver of DE. BMP4 specifies ventral/intestinal fate. FGF2 supports DE formation via ERK1/2 signaling.
Cell Culture Media & Supplements	mTeSR1 / mTeSR Plus [31], N2B27 Supplement [9], RPMI 1640 [31]	Defined media for maintaining pluripotency (mTeSR) and for robust, serum-free differentiation (N2B27/RPMI).
Extracellular Matrices	hPSC-qualified Matrigel [31]	Provides a defined substrate for the feeder-free culture of pluripotent stem cells prior to differentiation.
Critical Assay Reagents	Antibodies: anti-SOX17, anti-FOXA2, anti-T(Brachyury) [4], RT-qPCR primers for SOX17, FOXA2, TBXT	Essential for molecular characterization of differentiated cells to confirm successful endoderm generation.

The directed differentiation of definitive endoderm in gastruloids requires a deep understanding of the dynamic and interconnected roles of the WNT, ACTIVIN/Nodal, and BMP signaling pathways. WNT initiates the process, ACTIVIN/Nodal provides the primary driving force, and BMP patterns and specifies regional identity. The protocols and tools detailed in this Application Note provide a framework for researchers to optimize their own systems. By precisely controlling the timing and concentration of these signals, it is possible to reduce the inherent variability of 3D models and generate robust, reproducible, and functionally patterned endodermal tissues for downstream research and therapeutic applications.

Advanced Protocols for Robust Definitive Endoderm Differentiation and Morphogenesis

Gastruloids are three-dimensional (3D) in vitro structures that mimic key aspects of embryonic development, including spatial organization and germ layer specification [33]. These engineered models of peri-gastrulation provide unprecedented insights into early lineage specification and the morphogenetic events that shape mammalian development [33]. For research on definitive endoderm (DE) differentiation, gastruloids offer a valuable platform to study the underlying mechanisms and signaling pathways in a system that recapitulates aspects of in vivo development [34]. This protocol details a core method for generating gastruloids from mouse embryonic stem cells (mESCs) and guiding them through germ layer specification, with a specific focus on establishing a foundation for DE differentiation research.

Materials

Research Reagent Solutions

The following table lists the essential materials required for the successful execution of this protocol.

Reagent/Material	Function/Description	Example or Note
Mouse Embryonic Stem Cells (mESCs)	The starting cellular material for gastruloid formation.	Ensure cells are pluripotent and maintained in a naive state.
Aggregation Plate (e.g., U-bottom low-adhesion)	Facilitates the formation of uniform 3D cell aggregates.	Essential for the initial symmetry-breaking event.
Basal Medium	The base nutrient medium for cell culture.	e.g., Advanced DMEM/F12.
CHIR99021	A small molecule GSK-3β inhibitor that activates Wnt/β-catenin signaling.	Used to initiate gastruloid patterning; concentration must be optimized.
B27 Supplement	A serum-free supplement formulated to support neuronal cell survival.	Commonly used in gastruloid culture media.
N-2 Supplement	A defined supplement for the growth of neural cells.	Often used in conjunction with B27.
Recombinant Growth Factors	Proteins that direct cell fate decisions.	e.g., Activin A (for endoderm induction) [34].
Small Molecule Inducers	Chemically defined components for directed differentiation.	Alternative to recombinant proteins for scalable, defined systems [34].

Methods

mESC Aggregation and Gastruloid Initiation

• Cell Preparation: Harvest and count mESCs. Ensure the cells are in a single-cell suspension.
• Aggregation: Plate a defined number of cells (e.g., 300-500 cells) per well in a U-bottom low-adhesion 96-well plate in gastruloid initiation medium.
• Centrifugation: Centrifuge the plate at low speed (e.g., 300-500 × g for 3-5 minutes) to pellet the cells at the bottom of each well, promoting aggregate formation.
• Culture: Culture the aggregates for 48 hours. Within this period, the cells should form a single, spherical aggregate per well.

The following diagram illustrates the initial workflow from cell preparation to the formation of the early aggregate.

Germ Layer Specification and Patterning

After the initial aggregate formation, the key step is the induction of symmetry breaking and germ layer patterning. This is primarily achieved through the timed activation of the Wnt/β-catenin signaling pathway [33].

• Wnt Activation: At 48 hours post-aggregation (designated as Day 0 of differentiation), transfer the aggregates to gastruloid differentiation medium supplemented with CHIR99021.
• Concentration Optimization: The concentration of CHIR99021 is critical and typically ranges from 1-3 µM. This must be empirically optimized for specific cell lines and experimental setups.
• Extended Culture: Culture the aggregates with CHIR99021 for a defined period, often 2-4 days, to induce the formation of a polarized structure with emergent braided regions, indicative of germ layer specification and axial organization.

The following flowchart outlines the key decision points and morphological changes during the patterning phase.

Quantitative Assessment of Germ Layer Formation

To quantitatively evaluate the success of germ layer specification, particularly towards definitive endoderm, genomic accessibility analysis and similarity scoring can be employed. These methods move beyond simple marker analysis to provide a more comprehensive quality assessment.

• Genomic Analysis: Perform assays such as ATAC-seq on the gastruloids to assess chromatin architecture reconfiguration. Successful DE induction is characterized by open chromatin regions that allow binding of key DE transcription factors [34].
• Similarity Scoring: Utilize quantitative algorithms, such as organ-specific gene expression panels (Organ-GEP), to calculate a similarity score between the transcriptional profile of your gastruloid-derived cells and the target human organ or tissue (e.g., stomach, lung) [35]. This provides a percentage-based similarity score for standardized quality control.

The table below summarizes the key parameters for a successful definitive endoderm induction protocol based on recent research.

Parameter	Target Outcome	Quantitative Measure
System Definition	Chemically defined, recombinant protein-free [34].	Use of only small-molecule components (e.g., a 4C system).
Differentiation Efficiency	High-efficiency DE specification [34].	>80% of cells expressing DE markers (e.g., SOX17, FOXA2).
Functional Potential	Ability to differentiate into functional DE-derived lineages [34].	Successful generation of hepatocytes, lung organoids, or pancreatic β cells.
Chromatin State	Reconfiguration of chromatin architecture [34].	Genomic accessibility at key DE transcription factor binding sites.
Transcriptomic Similarity	Molecular signature resembling target tissue [35].	High similarity score (%) via algorithms like StGEP or LuGEP.

Signaling Pathways in Definitive Endoderm Differentiation

The differentiation of pluripotent stem cells towards definitive endoderm relies on the precise activation and inhibition of key developmental signaling pathways. Research into chemically defined systems has highlighted the role of transcriptional regulators like TEAD3, in addition to established pathways such as Nodal/Activin and Wnt [34].

Within the broader context of definitive endoderm differentiation in gastruloid research, achieving high and consistent yields of endodermal cell types remains a significant challenge. Conventional gastruloid protocols often exhibit inherent variability and a tendency for neuromesodermal progenitors (NMPs) to adopt a mesodermally biased fate, thereby limiting the representation of endoderm and its derivatives [36] [9]. This application note details a targeted protocol modification—an early pulse of retinoic acid (RA)—that robustly enhances endoderm yield and promotes the formation of posterior embryo-like structures in human gastruloids. The methodology is grounded in the mechanistic understanding that RA signaling corrects the biased differentiation potential of NMPs, steering them toward a more balanced fate that supports endodermal and neural lineages [36]. The following sections provide a comprehensive summary of the quantitative evidence, a detailed experimental protocol, and essential resources for implementation.

Key Findings and Quantitative Outcomes

The implementation of an early RA pulse, in conjunction with later Matrigel supplementation, has been demonstrated to significantly alter the morphological and compositional outcomes of human gastruloids. The table below summarizes the key quantitative findings from the characterization of these RA-gastruloids.

Table 1: Quantitative Outcomes of RA-Gastruloid Protocol

Parameter	Result in RA-Gastruloids	Comparison to Conventional Gastruloids	Source
Success Rate	89% of elongated gastruloids exhibited both segmented somites and a neural tube-like structure.	Not observed with Matrigel supplementation alone.	[36]
Key Structures Formed	Neural tube flanked by segmented somites.	Elongated structures with all three germ layers, but lacking advanced morphological features.	[36]
Cell Types Identified	Neural crest, neural progenitors, renal progenitors, myocytes.	Primarily mesodermal and endodermal derivatives; neural tube cells were notably absent.	[36]
Developmental Progression	Aligned to E9.5 mouse and CS11 cynomolgus monkey embryos (via in silico staging).	Progressed to an earlier developmental stage.	[36]
Protocol Robustness	High reproducibility across five independent experiments.	Higher inter-individual variation.	[36]

Mechanism of Action: RA Signaling in Endoderm Enhancement

The efficacy of the RA pulsing protocol is underpinned by its ability to restore the bipotentiality of NMPs. scRNA-seq analysis of conventional human gastruloids revealed a deficiency in neural tube cell formation and an apparent mesodermal bias, which was correlated with lower expression of RA-synthesizing enzymes (e.g., ALDH1A2) and higher expression of RA-degrading enzymes (e.g., CYP26A1) compared to mouse models [36]. The early, discontinuous RA pulse is hypothesized to compensate for this deficient endogenous RA signaling network, thereby rebalancing the differentiation potential of NMPs toward both posterior neural and paraxial mesodermal fates, which is a prerequisite for the coordinated development of subsequent structures, including the endoderm [36] [37].

Diagram: RA Signaling Pathway in Gastruloid Patterning

Detailed Experimental Protocol

This section provides a step-by-step methodology for generating human RA-gastruloids with enhanced endoderm potential.

Materials and Reagent Setup

Table 2: Essential Research Reagents and Solutions

Reagent/Solution	Function/Purpose	Notes/Specifications
Human Pluripotent Stem Cells (hPSCs)	Starting cell population for gastruloid formation.	Maintained in a primed pluripotency state.
Retinoic Acid (RA)	Signaling molecule to direct NMP fate.	Prepare a stock solution and use at optimized concentrations (e.g., 100 nM-1 µM). Light-sensitive.
CHIR99021 (CHIR)	Small molecule agonist of WNT signaling.	Used for pre-treatment and during gastruloid induction. Concentration requires optimization.
Matrigel	Extracellular matrix providing structural support and signaling cues.	Critical for later-stage morphological development.
Aggregation Plates	Platform for forming uniform 3D aggregates.	U-bottom 96-well or 384-well plates are recommended.
Defined Media (e.g., N2B27)	Base medium for gastruloid differentiation.	Removing serum reduces batch-to-batch variability [9].

Step-by-Step Workflow

The following workflow outlines the critical temporal sequence of actions and signaling perturbations required for successful RA-gastruloid formation.

Diagram: RA-Gastruloid Experimental Workflow

Protocol Steps:

• Cell Aggregation (Day 0):

  • Accurately count hPSCs and resuspend them in gastruloid induction medium. The initial cell seeding number is a critical parameter and should be optimized (e.g., a larger seeding may be beneficial) [36].
  • Seed the cell suspension into a U-bottom 96-well or 384-well plate to facilitate the formation of uniform aggregates via forced aggregation. Using microwells or hanging drops can improve control over the initial cell count and reduce gastruloid-to-gastruloid variability [9].
  • Centrifuge the plate to gather cells at the bottom of each well.

• Early RA Pulse (Day 1 - 24 hours after seeding):

  • At 24 hours post-aggregation, supplement the gastruloid induction medium with a pulse of RA. The effective concentration range is 100 nM to 1 µM [36].
  • This early pulse is the most critical intervention for inducing subsequent trunk-like structures.

• RA Withdrawal (Day 2):

  • Carefully remove the medium containing RA and replace it with fresh gastruloid induction medium without RA. Temporally discontinuous exposure is essential, as continuous RA exposure can perturb the differentiation of other cell types.

• Matrigel Supplementation (Day 3 and onward):

  • Beginning at 48 hours after aggregation, supplement the medium with Matrigel (e.g., at a 10% final concentration) to support further elongation and morphogenesis. Matrigel alone is insufficient to induce neural tube or somites but is required in combination with the early RA pulse [36].

• Culture and Monitoring (Days 3-5):

  • Continue culture, refreshing the medium with Matrigel as needed.
  • Monitor gastruloids for elongation and the emergence of posterior morphological structures, such as a neural tube-like structure and segmented somites, which typically become apparent around day 5.

Troubleshooting and Protocol Optimization

• Variability in Endoderm Morphology: Endoderm progression is highly sensitive to coordination with mesoderm-driven axis elongation [9]. To reduce variability, ensure strict control over initial cell seeding numbers and use defined media components. Machine learning approaches that link early morphological parameters to later outcomes can also help predict and steer endodermal morphotype [9].
• Handling RA: RA is light-sensitive and can isomerize. Prepare stock solutions and perform manipulations under dim light if necessary to maintain stability [38].
• Lack of Elongation or Structure Formation: If gastruloids fail to elongate or form structures, verify the activity and concentration of key signaling molecules like CHIR99021 (WNT agonist). The concentration may require titration based on the specific hPSC line used [36] [9].

The RA pulsing protocol represents a significant advance in the field of synthetic embryology, providing a robust and scalable model for studying posterior embryonic development and endoderm specification. Future work may involve further personalization of the protocol, such as matching the timing of interventions to the internal state of individual gastruloids to buffer intrinsic variability [9]. Furthermore, this model is highly amenable to chemical and genetic perturbations, making it an powerful platform for decoding the signaling dynamics (e.g., WNT and BMP) that govern early human embryogenesis and for modeling developmental disorders [36]. In conclusion, the strategic application of an early RA pulse is a highly effective method to enhance endoderm yield and structural organization in human gastruloids, offering researchers a more faithful and reproducible in vitro system.

The efficient and robust differentiation of pluripotent stem cells into definitive endoderm (DE) is a critical step for generating tissues of the respiratory and digestive tracts, as well as organs such as the liver, pancreas, and thyroid [23]. Recent advances in mechanobiology have revealed that physical cues in the cellular microenvironment are as pivotal as biochemical factors in directing cell fate. Among these cues, cell size has emerged as a key regulator of cellular physiology and differentiation capacity [23]. Studies demonstrate that DE differentiation is accompanied by a significant reduction in cell size and an increase in cell stiffness [23]. The external application of hypertonic pressure, which accelerates this natural size diminution, has been shown to significantly and specifically enhance the efficiency of DE specification [23]. This application note details the protocols and mechanistic insights for leveraging hypertonic pressure to improve DE differentiation, framed within research on gastruloid models.

Background and Rationale

The Role of Cell Size in Endoderm Specification

During the directed differentiation of human pluripotent stem cells (hPSCs) into DE, cell size decreases progressively [23]. This size reduction is not a mere consequence of differentiation but appears to be an active driver of the process. Flow cytometry and volumetric analyses confirm that DE cells are statistically smaller than their pluripotent precursors, a phenomenon not solely attributable to changes in cell cycle phases [23].

Hypertonic Pressure as a Tool for Fate Control

Hypertonic pressure acts as an external mechanical cue that induces osmotic stress, leading to rapid water efflux and consequent cell shrinkage. This physical intervention mimics the natural size diminution observed during endodermal specification. Research on mouse embryonic stem cells (mESCs) has shown that hypertonic pressure can also influence pluripotency and self-renewal, underscoring the broad role of osmotic stress in stem cell biology [39]. In the context of DE differentiation, applying hypertonic pressure creates a permissive mechanical environment that enhances differentiation efficiency [23].

Key Mechanosensitive Signaling Pathway

The mechanosensitive pathway involving actomyosin, angiomotin (AMOT), and Yes-associated protein (YAP) is central to this process.

• Actomyosin Activity: Hypertonic pressure-induced cell shrinkage stimulates actomyosin contractility [23].
• AMOT Nuclear Translocation: The actomyosin activity promotes the translocation of AMOT into the nucleus [23].
• YAP Inactivation: Nuclear AMOT facilitates the inactivation of YAP, a transcriptional co-activator implicated in cell proliferation and fate decisions. YAP suppression creates a signaling environment conducive to endoderm differentiation [23] [39].

The following diagram illustrates this core signaling pathway:

The enhancing effect of hypertonic pressure on DE differentiation is supported by quantitative cellular and molecular data.

Table 1: Quantitative Effects of Hypertonic Pressure on Cell Size and Differentiation

Parameter	Experimental Group	Control Group (Isotonic)	Measurement Method	Citation
Cell Size (Relative)	Significantly smaller	Larger	Flow cytometry (FSC), Coulter counter, 3D confocal microscopy	[23]
DE Differentiation Efficiency	Significantly enhanced	Baseline	Flow cytometry for DE markers (e.g., CXCR4, SOX17)	[23]
Integrin Tension (56-pN/12-pN)	Higher in DE cells	Lower in hPSCs	Reversible shearing DNA-based tension probe	[23]
Nuclear YAP Localization	Increased cytoplasmic/inactivated	Increased nuclear/active	Immunofluorescence, Western Blot	[23] [39]

Table 2: Effects of Hypertonic Pressure Across Different Stem Cell Models

Cell Type	Hypertonic Effect	Key Observed Outcomes	Citation
Human PSCs	Promotes definitive endoderm differentiation	Actomyosin-dependent AMOT nuclear translocation; YAP inhibition	[23]
Mouse ESCs	Affects pluripotency and self-renewal	Depolymerization of F-actin; limits YAP nuclear transmission; cell-cycle arrest	[39]

Experimental Protocols

Protocol 1: Hypertonic Pressure-Assisted DE Differentiation from hPSCs

This protocol integrates hypertonic treatment into a standard DE differentiation workflow, adapted from a cost-effective, chemically defined system [23] [6].

Materials and Reagents

Table 3: Research Reagent Solutions for Hypertonic DE Differentiation

Reagent	Function	Example/Details
hPSCs	Starting cell population	H1 or H9 hESC lines; WTB or WTC hiPSC lines [6].
Matrigel/Vitronectin	Extracellular matrix coating for cell adhesion	Provides a defined substrate for hPSC maintenance and differentiation [6].
Base Medium	Differentiation basal medium	DMEM/F12 supplemented with Vitamin C (71 µg/mL) [6].
CHIR99021	GSK-3β inhibitor/Wnt activator	Used at 3 µM for initial differentiation pulse [6].
Hypertonic Agent	Induces cell shrinkage	e.g., Sorbitol or other osmolytes; concentration must be optimized.
Y-27632	ROCK inhibitor	Improves cell survival after passaging and during initial differentiation stages [6].
LDN193189	BMP pathway inhibitor	Can be used to improve DE purity [6].

Step-by-Step Procedure

• hPSC Culture and Seeding: Maintain hPSCs in a pluripotent state using defined media (e.g., TeSR-E8) on Matrigel- or Vitronectin-coated plates. For differentiation, harvest hPSCs using Accutase and seed them at an appropriate density (e.g., (2.5 \times 10^5) cells/cm²) in the presence of 10 µM Y-27632 to enhance survival [6].
• Initiation of DE Differentiation: Once cells reach ~80% confluence, replace the maintenance medium with DE induction basal medium (see Table 3) containing 3 µM CHIR99021. Culture the cells for 24 hours [6].
• Application of Hypertonic Pressure: After the initial CHIR99021 pulse, replace the medium with fresh DE induction basal medium. Add the optimized concentration of a hypertonic agent (e.g., Sorbitol). Culture the cells for the next 24-48 hours.
  • Critical Note: The optimal concentration and duration of hypertonic treatment must be determined empirically for each cell line and experimental setup to maximize efficiency while minimizing cell death.
• Continuation of Differentiation: Following the hypertonic pulse, continue the DE differentiation by replacing the medium with standard DE induction basal medium (without CHIR99021 or hypertonic agent) for an additional 1-3 days, with daily medium changes.
• Validation of Differentiation: Analyze the resulting cells at day 4-5 for DE markers.
  • Flow Cytometry: Analyze the expression of surface marker CXCR4 (CD184) and intracellular transcription factors SOX17 and FOXA2 [6].
  • Immunofluorescence: Fix cells and stain for key DE markers such as SOX17, FOXA2, GATA4, and GATA6. Use DAPI for nuclear counterstaining [6].

The overall workflow is summarized below:

Protocol 2: Validating Mechanosensitive Signaling in Gastruloids

Gastruloids, 3D aggregates of stem cells, are powerful models for studying lineage specification in a context that mimics embryonic development [13] [14] [4]. This protocol outlines how to perturb and observe the mechanosensitive pathway in these structures.

Key Materials

• mESCs or hPSCs for gastruloid formation.
• N2B27 medium for aggregate culture.
• CHIR99021 for Wnt activation and symmetry breaking.
• Inhibitors/Activators: e.g., Blebbistatin (myosin II inhibitor), Verteporfin (YAP inhibitor).
• Hypertonic Agent (e.g., Sorbitol).

Procedure

• Gastruloid Formation: Aggregate mESCs or hPSCs in low-attachment 96-well plates in N2B27 medium. A typical protocol involves forming aggregates of 300-500 cells [14] [4].
• Induction and Perturbation: At the appropriate time (e.g., day 2), administer a 24-hour pulse of 3 µM CHIR99021 to induce gastrulation-like events [14] [4].
  • Experimental Groups:
    • Group 1 (Control): Culture in standard N2B27 medium.
    • Group 2 (Hypertonic): Culture in N2B27 medium made hypertonic with an osmolyte.
    • Group 3 (Inhibition): Culture in hypertonic N2B27 medium supplemented with 10-20 µM Blebbistatin.
• Fixation and Analysis: Harvest gastruloids at specific time points (e.g., day 4-5).
  • Immunostaining: Perform whole-mount staining for E-cadherin (to visualize endoderm-like regions), T-Brachyury (mesoderm), SOX17 (definitive endoderm), and YAP (localization) [23] [4].
  • Imaging: Acquire images using confocal microscopy and analyze the spatial distribution of markers and the nuclear-to-cytoplasmic ratio of YAP.

Application in Drug Discovery and Disease Modeling

The enhancement of DE differentiation efficiency through hypertonic pressure has direct implications for regenerative medicine and drug screening.

• Cost-Effective Production: Improving the yield of DE cells from hPSCs reduces the cost and increases the scalability of generating endodermal derivatives like hepatocytes and pancreatic beta cells for cell therapy [6] [40].
• High-Throughput Screening: Robust and efficient DE differentiation protocols are essential for creating in vitro models of human diseases (e.g., monogenic diabetes, liver fibrosis) for high-throughput drug screening [6] [40]. Hypertonic treatment can contribute to the reproducibility required for such applications.
• Gastruloid Quality Control: The variability in tissue morphogenesis in 3D models like gastruloids is a known challenge [13]. Physical interventions like hypertonic pressure could be used to steer morphotype choice and reduce variability, thereby improving the quality and usability of these models for developmental studies and toxicology [13].

The application of hypertonic pressure represents a novel and powerful mechanobiological strategy to enhance the differentiation of pluripotent stem cells into definitive endoderm. By actively reducing cell size, this intervention harnesses a natural biophysical process to drive fate specification through the actomyosin-AMOT-YAP signaling axis. The protocols outlined herein provide a framework for researchers to implement this approach in both 2D culture and 3D gastruloid models, promising advances in the production of endodermal lineages for therapeutic and drug discovery applications.

Within research on definitive endoderm differentiation and gastruloid formation, the selection of an appropriate culture platform is a critical determinant of experimental success. These three-dimensional aggregates of mouse embryonic stem cells recapitulate key events of early embryogenesis, including germ layer specification and axial organization [41]. The culture platform must support reproducible, high-fidelity outcomes while accommodating the specific demands of the protocol, which can be highly sensitive to aggregation conditions. This application note provides a detailed comparison of three common platforms—96-well plates, microwell arrays, and shaking platforms—framed within the context of gastruloid research. We summarize key quantitative data, provide actionable protocols, and outline decision-making workflows to guide researchers in selecting and implementing the optimal system for their investigative needs.

Platform Comparison and Selection Guide

The choice between 96-well plates, microwell arrays, and shaking platforms involves trade-offs between throughput, control over the initial aggregation, and the ability to scale the culture process. The table below provides a direct comparison of their core characteristics.

Table 1: Quantitative Comparison of Culture Platforms for Gastruloid Research

Feature	96-Well Plates	Microwell Arrays	Shaking Platforms (e.g., Orbital Shakers)
Typical Well/Reactor Volume	100–300 µL (standard 96-well) [42]	Microwells range from 5–100 µm in diameter and 3–3.5 µm in depth [43]	Shake flasks: 10 mL – 4 L; Bioreactors: 1.5 L – 2500 L [44]
Common Well Number/Format	96, 384, 1536 wells [45] [42]	Thousands of wells on a single chip [43]	Single vessels, scalable in parallel
Primary Advantage	Standardization, high-throughput compatibility, and ease of use [45] [42]	High-content imaging of thousands of confined communities in parallel [43]	Consistent hydrodynamics for easy scale-up from µL to thousands of liters [44]
Optimal Application in Gastruloid Research	Initial high-throughput screening of differentiation conditions; extended culture with embedding (e.g., in Matrigel) [41]	Studying the effects of physical confinement and initial cell number on early aggregate formation and symmetry breaking	Larger-scale production of gastruloids or precursor cells; process development
Key Technical Considerations	- Well shape (U-bottom ideal for aggregation) [42]- Surface treatment (low-adhesion critical)- Material autofluorescence	- Requires microfabrication (e.g., silicon etching) [43]- Sealing with a gel-coated coverslip for feeding	- Gentle shear stress and bubble-free surface aeration support cell viability [44]- Power input is transferred by the vessel wall

Experimental Protocols

Protocol: Gastruloid Culture in 96-Well Plates

This optimized protocol is adapted for the reproducible generation and extended culture of mouse embryonic stem cell-derived gastruloids [41].

Workflow Overview

Research Reagent Solutions

Item	Function/Benefit in Protocol
U-bottom 96-well plate	The rounded well bottom facilitates the self-assembly of cells into a single, central aggregate and minimizes wall adhesion [42].
Low-adhesion surface treatment	Prevents cells from sticking to the well walls, forcing them to aggregate into a 3D structure.
10% Matrigel	Embedding at 96 hours post-aggregation provides a supportive 3D extracellular matrix that enables extended culture and models a more complex tissue environment [41].

Step-by-Step Methodology

• Plate Preparation: Use a 96-well plate with a U-bottom and low-adhesion surface. Pre-equilibrate the plate with the appropriate initial differentiation medium.
• Cell Seeding: Harvest and dissociate mouse embryonic stem cells (mESCs) to a single-cell suspension. Seed the cells into the prepared plate at a defined density (e.g., 300-500 cells/well in 100-150 µL of medium). Centrifuge the plate (e.g., 300 × g for 3 minutes) to gently pellet the cells into the bottom of the U-well, ensuring uniform aggregation initiation [45].
• Aggregation and Early Culture: Incubate the plate for 96 hours under standard culture conditions (37°C, 5% CO2). During this time, the cells will self-assemble into a single gastruloid per well.
• Embedding for Extended Culture: At 96 hours post-aggregation, carefully embed the formed gastruloids in 10% Matrigel according to the optimized protocol [41]. This step is critical for supporting the structure and continued development of the gastruloids for up to 168 hours total culture.
• Medium Changes and Monitoring: Perform partial medium changes every 48 hours, taking care not to disturb the aggregates or the Matrigel dome. Monitor gastruloid morphology daily using bright-field or fluorescence microscopy.

Protocol: Assembling Microbial Communities in Microwell Arrays

While not used directly for mammalian gastruloid culture in the literature reviewed, the principles of microwell arrays are highly relevant for studying the initial confinement of cells. This protocol, using bacteria, demonstrates the platform's utility for tracking the development of thousands of simple communities in parallel [43].

Workflow Overview

Research Reagent Solutions

Item	Function/Benefit in Protocol
Silicon Microwell Array	The core platform, fabricated via photolithography and etching, providing thousands of physically isolated micro-environments [43].
Parylene N Coating	A biocompatible polymer layer used in the fabrication process and later lifted off to remove surface-associated cells, leaving only those confined in the microwells [43].
Agarose Gel-Coated Coverslip	Seals the array while providing a medium-infused support that feeds bacterial growth within the microwells, maintaining hydration and nutrient supply [43].

Step-by-Step Methodology

• Array Fabrication: Fabricate the microwell arrays via photolithography and deep reactive ion etching (DRIE) into a parylene-coated silicon wafer. Well diameters can range from 15–100 µm with depths of ~3–3.5 µm [43].
• Surface Functionalization: To wet the wells and/or functionalize the surface, apply a droplet of protein solution (e.g., bovine serum albumin) over the array. Remove the solution and dry the wafer.
• Cell Seeding: Apply a solution containing the fluorescently labeled cells (e.g., P. aeruginosa constitutively expressing mCherry or GFP) to the array. After an incubation period, remove the bacterial solution and dry the wafers, leaving behind cells in the microwells and on the surface.
• Parylene Lift-Off: Use adhesive tape to perform a "parylene lift-off," which physically removes the surface-associated bacteria while leaving the cells trapped within the microwells viable.
• Sealing and Imaging: Place the silicon chip array-side down onto a sterile coverslip coated with a thin layer of medium-infused agarose gel. This creates a sealed chamber for culture. Image the arrays over time using time-lapse fluorescence microscopy to track the growth and interactions of the confined communities [43].

Protocol: Scale-Up Culture using Orbitally Shaken Systems

Shaking platforms are instrumental for scaling up cell culture processes. The consistent hydrodynamics of orbital shaking allows for a seamless transition from small-scale screening to larger production volumes [44].

Workflow Overview

Research Reagent Solutions

Item	Function/Benefit in Protocol
Orbitally Shaken Bioreactor (e.g., Kuhner OSB)	Cylindrical vessels, often using single-use bags, that provide bubble-free surface aeration and low-shear mixing, ideal for sensitive cell types [44].
Single-Use Bioreactor Bag	Gamma-sterilized, pre-equipped with ports for feeding and sensors; eliminates cleaning and sterilization validation, reducing cross-contamination risk [44].
Built-in Chemo-Optical Sensors	Enable non-invasive online monitoring of key parameters like dissolved oxygen (DO) and pH, critical for maintaining process control and consistency [44].

Step-by-Step Methodology

• Vessel Preparation: For a disposable system, aseptically connect a pre-sterilized single-use bag to the gas exchange and sensor lines of the orbitally shaken bioreactor system.
• Inoculation and Parameter Setting: Inoculate the bioreactor with the cell culture inoculum. Set the shaking parameters (orbital diameter and frequency), temperature, and gas flow rates according to the optimized protocol for the specific cell line (e.g., mESCs or differentiated progenitors).
• Process Monitoring: Continuously monitor and log process parameters such as dissolved oxygen (DO) and pH. The orbital shaking motion creates a large gas transfer area, providing high oxygen transfer (kLa) values through bubble-free surface gassing [44].
• Feeding and Harvest: Perform fed-batch or perfusion feeding as required. The gentle orbital shaking motion ensures homogeneous mixing without damaging cells, preventing extensive frothing that is common in stirred-tank bioreactors with bubble aeration [44]. Harvest the cells or conditioned medium for downstream analysis.

The Scientist's Toolkit: Essential Material Solutions

Table 2: Key Research Reagents and Materials

Item	Function/Benefit	Recommended Application
U-Bottom Microplates	Rounded well bottom facilitates the formation of a single, central aggregate and is ideal for cells in suspension and spheroids [42].	Gastruloid aggregation in 96-well plates.
Low-Adhesion Surface Treatment	A chemically modified surface that minimizes cell attachment, promoting 3D cell-cell interactions over 2D adhesion.	All platforms to ensure scaffold-free 3D aggregation.
Matrigel	A basement membrane extract providing a complex 3D environment that supports complex tissue morphogenesis and extended culture.	Embedding gastruloids for post-aggregation development [41].
Cycloolefin (COC) Plates	Polymer material with excellent ultraviolet light transmission and low autofluorescence, ideal for high-content imaging.	Fluorescence imaging of reporter cell lines in microwell or microplate formats [45] [42].
Single-Use Bioreactor Bag	Pre-sterilized, disposable culture vessel with integrated sensors; eliminates cleaning and reduces validation workload.	Scale-up culture in orbitally shaken bioreactors [44].

Decision Workflow for Platform Selection

Use the following workflow to select the most appropriate culture platform based on the primary goal of your experiment.

In the realm of definitive endoderm differentiation and gastruloid research, the extracellular matrix (ECM) transcends its traditional role as a physical scaffold to become an instructive biological niche that actively directs cell fate. Matrigel, a basement membrane extract from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, is a critical component in various protocols for its efficacy in promoting stem cell growth and self-organization [46] [47]. Its complex composition, including laminin (a major component), collagen IV, heparan sulfate proteoglycans, entactin/nidogen, and numerous growth factors, closely mimics the in vivo environment that cells encounter during embryonic development [47]. Within the context of definitive endoderm differentiation and subsequent gut-tube formation, Matrigel provides not merely structural support but essential biochemical and biophysical cues that guide morphogenetic processes, including the transition from two-dimensional endoderm sheets to three-dimensional intestinal organoids with functional epithelial domains [48] [49]. This application note details the standardized protocols and mechanistic insights for leveraging Matrigel to achieve robust endoderm morphogenesis and gut-tube formation, framed within contemporary gastruloid research.

Biological Mechanism: How Matrigel Influences Cell Fate

Biochemical Signaling and Lineage Specification

Matrigel's role in driving stem cell lineage commitment is significant and complex. Research directly investigating its role in embryoid bodies has demonstrated that Matrigel actively promotes endoderm differentiation while concurrently inhibiting ectoderm specification [46]. This effect is not solely due to the physical constraints of the matrix, as control experiments using agarose—an inert polysaccharide that provides similar physical confinement—did not produce the same lineage bias [46]. This indicates that the biochemical composition of Matrigel is a primary driver of these fate decisions. The matrix contains inherent growth factors and signaling molecules that activate key pathways involved in endodermal patterning.

Furthermore, studies have shown that specific integrin-ECM interactions are required for efficient definitive endoderm differentiation. Fibronectin (FN) and Vitronectin (VTN) have been identified as key ECM components that promote definitive endoderm formation through interactions with integrins α5 (ITGA5) and αV (ITGAV), respectively [50]. Knockdown of these integrins disrupts the differentiation process, underscoring that ECM signaling is not merely permissive but fundamentally instructive [50].

Synergy with Morphogenetic Pathways

The biochemical cues provided by Matrigel work in synergy with exogenous growth factors used in differentiation protocols. During the key morphogenetic step following definitive endoderm induction, the combined activation of WNT and FGF signaling is required to pattern the endoderm into CDX2+ mid/hindgut tissue and initiate a gut tube-like morphogenesis [48] [49]. This process involves the formation of three-dimensional spheroids that bud from a monolayer epithelium, a critical step that is supported by the 3D environment provided by Matrigel [48]. The matrix facilitates the necessary epithelial reorganization and budding, ultimately allowing these spheroids to expand into complex intestinal organoids complete with villus-like and crypt-like structures [48] [51].

The following diagram illustrates the key signaling pathways and morphological stages involved in this process:

Experimental Protocols

Core Protocol: Generating Human Intestinal Organoids from PSCs

This protocol, adapted from Spence et al. and McCracken et al., directs the differentiation of human pluripotent stem cells (hPSCs) through developmental stages mimicking embryonic intestine formation, resulting in 3D intestinal organoids containing all major epithelial cell types [48] [49].

Stage 1: Definitive Endoderm Induction (3 Days)

• Starting Material: Human ESCs (e.g., H1, H9) or iPSCs maintained in mTeSR1 medium on hESC-qualified Matrigel.
• Day 0: Differentiate hPSCs to definitive endoderm using Activin A (100 ng/mL) in RPMI medium.
• Supplementation: Add increasing concentrations of defined FBS (0%, 0.2%, 2%) over the 3-day period to enhance efficiency.
• Quality Control: Successful differentiation is marked by high expression of transcription factors SOX17 and FOXA2. A control without Activin A should be included to monitor differentiation efficiency [48].

Stage 2: Mid/Hindgut Patterning and Spheroid Formation (4 Days)

• Day 3-7: Pattern definitive endoderm into CDX2+ mid/hindgut tissue using FGF4 (500 ng/mL) and WNT3a (500 ng/mL) in advanced DMEM/F12 medium.
• Critical Morphogenetic Event: During this stage, 3D mid/hindgut spheroids will begin to bud from the monolayer epithelium. This is a key indicator of successful patterning.
• Quality Control: Immunostaining for CDX2 is essential. Controls excluding FGF4 and/or WNT3a should be used to verify spheroid formation dependence on these factors [48].

Stage 3: 3D Intestinal Organoid Culture and Expansion (14-28 Days)

• Day 7+: Manually harvest the budding 3D spheroids. Embed them in droplets of Matrigel (Corning, catalog #354234) [48].
• Culture Setup: Plate the Matrigel droplets containing spheroids into Nunclon Delta surface tissue culture dishes. Overlay with intestinal growth medium.
• Growth Medium Composition: Advanced DMEM/F12 supplemented with key pro-intestinal growth factors:
  • WNT3a (to maintain stem/progenitor cells)
  • R-spondin 1 (to potentiate WNT signaling)
  • Noggin (a BMP antagonist that promotes epithelial morphogenesis)
  • EGF (to stimulate proliferation)
• Maturation: Culture the embedded spheroids for 2-4 weeks, with regular medium changes. During this time, they will proliferate and expand into complex intestinal organoids with villus-like and crypt-like domains [48] [49].

Protocol for Gastruloid Patterning and Screening

For research focusing on 2D gastruloids—an elegant model for studying early cell fate decisions and spatial patterning—recent advances in microarray technology enable high-throughput screening. The following workflow is adapted from microraft array-based technology developed for assaying and sorting individual gastruloids [52].

1. Microraft Array Fabrication and Patterning:

• Fabricate arrays of large (789 µm side length), flat, magnetic polystyrene microrafts.
• Use a novel photopatterning technique to deposit a central circular island (500 µm diameter) of ECM (e.g., Matrigel) onto each microraft with high accuracy.

2. Gastruloid Formation and Induction:

• Seed hPSCs onto the patterned arrays at confluent density, confining them to the circular ECM islands.
• To induce gastruloid formation, add BMP4 to the culture medium. This triggers a self-patterning signaling cascade, resulting in concentric rings of germ layers and extraembryonic trophectoderm-like cells [52].

3. Imaging and Analysis:

• Use an automated imaging system to capture transmitted light and fluorescence images of the entire array.
• Employ a computational image analysis pipeline to extract phenotypic features from each gastruloid (e.g., DNA content, marker expression).

4. Automated Sorting and Downstream Assay:

• Utilize an automated sorting system comprising a thin needle and magnetic wand to release and collect individual microrafts based on desired phenotypes.
• The sorted gastruloids can then be used for downstream applications like transcriptomic analysis (e.g., qPCR for genes like NOG and KRT7) to dissect heterogeneity [52].

Data Presentation and Analysis

Quantitative Outcomes of Intestinal Organoid Differentiation

The following table summarizes key quantitative outcomes and benchmarks for assessing successful intestinal organoid generation using the Matrigel-based protocol.

Table 1: Key Analytical Benchmarks for Intestinal Organoid Differentiation

Parameter	Measurement Method	Expected Outcome	Reference
DE Induction Efficiency	Flow Cytometry / IF Staining (SOX17, FOXA2)	>70% SOX17+ cells	[48] [50]
Hindgut Patterning	IF Staining (CDX2)	>90% CDX2+ cells in spheroids	[48]
3D Spheroid Formation	Bright-field Microscopy	Budding spheroids visible by day 4-7 of patterning	[48] [49]
Organoid Cellular Composition	IF Staining & Gene Expression	Presence of enterocytes, goblet, Paneth, and enteroendocrine cells	[48] [51]
Functional Maturation	Peptide transport assay / Mucin secretion	Functional dipeptide transport system; mucin secretion into lumen	[48]

Reagent Toolkit for Endoderm morphogenesis

A successful experiment relies on a carefully selected set of reagents. The table below catalogues essential research solutions for implementing the described protocols.

Table 2: Research Reagent Solutions for Endoderm and Gut Tube Morphogenesis

Reagent / Material	Specific Function	Application Notes	Reference
Corning Matrigel Matrix for Organoid Culture	Provides a 3D basement membrane scaffold for spheroid embedding and growth; promotes self-organization.	Phenol red-free formulation optimized for organoid culture. Must be kept on ice to prevent polymerization.	[47]
Activin A	TGF-β family cytokine used to induce definitive endoderm from PSCs by mimicking Nodal signaling.	Used at 100 ng/mL for 3 days in a low-serum medium. Critical for initiating the endodermal lineage.	[48] [49]
FGF4 & WNT3a	Synergize to pattern definitive endoderm into posterior mid/hindgut fate and drive CDX2 expression.	Combined use for 4 days is required for efficient CDX2 induction and 3D spheroid morphogenesis.	[48] [51]
Nunclon Delta Surface Dishes	Tissue culture surface that allows Matrigel droplets to form a 3D "bead".	Critical for protocol success; other surfaces cause Matrigel to spread thinly, preventing 3D growth.	[48]
Pro-Intestinal Growth Factors (R-spondin1, Noggin, EGF)	Support the expansion and maturation of intestinal tissue: R-spondin1 potentiates Wnt, Noggin inhibits BMP, and EGF stimulates proliferation.	Added to the medium during the prolonged organoid expansion phase (weeks 2-4+).	[48] [49]
Fibronectin & Vitronectin	Defined ECM proteins that promote definitive endoderm differentiation via integrin α5 and αV signaling.	A combination of FN+VTN can be used as a defined alternative to Matrigel for the DE induction stage.	[50]

Alternative and Advanced Matrices

While Matrigel is a cornerstone of 3D organoid culture, its complex and variable composition can be a limitation for certain applications [46] [50]. Researchers are increasingly exploring defined alternatives.

• Defined ECM Components: As identified in high-throughput screens, a combination of Fibronectin and Vitronectin provides a defined substrate that can enhance the efficiency of definitive endoderm differentiation compared to Matrigel by engaging specific integrin receptors (ITGA5 and ITGAV) [50].
• Chemically Defined Differentiation: Recent advances have led to the development of a fully chemically defined, growth factor-free system for definitive endoderm induction. This system uses a cocktail of four small molecules (4C) to specify endoderm fate by reconfiguring chromatin architecture, eliminating the need for recombinant proteins like Activin A and undefined matrices [34]. This represents a significant step toward scalable manufacture and clinical applications.
• Synthetic Hydrogels: Agarose, an inert polysaccharide, can be used to provide physical confinement. However, it lacks the biochemical cues of Matrigel and does not drive endoderm differentiation on its own, highlighting that the effects of Matrigel are not purely physical but biochemical [46]. This makes agarose a useful tool for control experiments designed to decouple mechanical from biochemical cues.

Matrigel remains an indispensable tool in the pipeline for modeling human endoderm development and gut-tube formation in vitro. Its ability to provide a complex, bioactive microenvironment that supports 3D morphogenesis and cellular differentiation is unmatched by current defined substrates for later stages of organoid culture. The protocols detailed herein, from generating complex intestinal organoids to screening patterned gastruloids, provide a robust framework for leveraging Matrigel's properties in basic research and drug development. However, the growing availability of defined ECM components and fully chemically defined systems signals a future trend toward greater precision, reproducibility, and clinical translatability in endoderm and gastruloid research.

Solving Variability and Enhancing Reproducibility in Endoderm Gastruloid Models

Within the expanding field of developmental biology, gastruloids have emerged as a powerful three-dimensional in vitro model for studying the principles of mammalian embryogenesis, including the specification of the definitive endoderm (DE) [9] [53]. DE gives rise to the respiratory and digestive tracts, liver, pancreas, and thyroid[citaiton:6] [54]. The reproducibility of gastruloid differentiation, however, is frequently challenged by significant variability in outcomes. This application note dissects the principal sources of this variability, spanning from pre-growth conditions to medium batches, and provides detailed, actionable protocols and data to enhance the robustness of definitive endoderm differentiation within gastruloid protocols.

Results and Data Analysis

Variability in gastruloid differentiation is a multi-level problem. It can be measured across morphological, gene expression, and cell composition parameters, and its sources are diverse [9].

Table 1: Levels and Sources of Gastruloid Variability

Level of Variability	Description	Key Sources
Experimental System	Differences arising from the chosen cell line and base protocol.	Cell line choice and genetic background; pre-growth conditions (e.g., 2i/LIF vs. Serum/LIF); cell aggregation method and initial cell number [9].
Between Experiments	Differences when the same protocol is repeated by the same lab.	Batch-to-batch differences in medium components (e.g., serum, Matrigel); cell passage number; personal handling techniques [9].
Within an Experiment (Gastruloid-to-Gastruloid)	Distribution of outcomes in morphology and cell composition within a single experiment.	Intrinsic heterogeneity of the stem cell population; fragile coordination between endoderm progression and axial elongation driven by the mesoderm; local microenvironment differences [13] [9].

The following table summarizes specific factors and their demonstrated impact on differentiation efficiency, providing a quantitative basis for diagnostic efforts.

Table 2: Impact of Specific Factors on Endoderm Differentiation

Factor	Experimental Manipulation	Impact on Differentiation	Key Findings
Cell Size	Application of hypertonic pressure to induce cell shrinkage [23].	Promotes DE specification.	A gradual decrease in cell size accompanies DE differentiation. Hypertonic pressure, which accelerates this size reduction, significantly enhanced DE differentiation efficiency in human PSCs. The effect is mediated by actomyosin-dependent nuclear translocation of AMOT and subsequent suppression of YAP activity [23].
ROCK Signaling	Inhibition of ROCK using small molecules (e.g., Fasudil) during early differentiation [54].	Induces DE and Anterior DE (ADE).	A high-content screen identified ROCK inhibition as a novel mechanism for DE induction in both mESCs and hESCs. ROCKi-induced DE efficiently gave rise to PDX1+ pancreatic progenitors, offering a potential replacement for biologics like Activin A [54].
Retinoic Acid (RA) Signaling	Early pulse of RA (0-24h) in human gastruloids [36].	Boosts neural tube and somite formation.	Human gastruloids exhibit low expression of RA-synthesizing enzymes (ALDH1A2). An early, discontinuous RA pulse, combined with later Matrigel, robustly induced posterior embryo-like structures (neural tube flanked by somites) by restoring the bipotential state of Neuromesodermal Progenitors (NMPs) [36].
Coordination Between Germ Layers	Machine-learning guided interventions based on early measurements [13] [9].	Steers endoderm morphotype choice.	The failure of DE to form proper gut-tube structures is often due to a lack of coordination with the elongating mesoderm. Learned predictive models can identify key drivers and guide pulsed interventions that boost the frequency of desired tubular morphotypes [13] [9].

Experimental Protocols

Protocol 1: Automated Microfluidic Screening for DE Differentiation Optimization

This protocol uses a microfluidic large-scale integration (mLSI) chip for high-throughput, automated screening of DE differentiation parameters, minimizing manually introduced variation [55].

Workflow Diagram:

Detailed Procedure:

• Chip Fabrication and Preparation:
  • Fabricate the mLSI chip using standard soft lithography. The design should incorporate a U-shaped pneumatic membrane valve to form and compartmentalize individual 3D cell cultures (~150 μm diameter) [55].
  • Sterilize the chip before use.
• 3D Cell Culture Seeding:
  • Prepare a single-cell suspension of human iPSCs (hiPSCs).
  • Load the cell suspension into the chip's flow layer. Use the U-shaped valves to trap and aggregate a defined number of cells, forming uniform 3D spheroids in each of the 128 culture units [55].
• Automated Differentiation and Screening:
  • Program the chip's pneumatic valves to perfuse different differentiation media in a systematic manner. This allows for the parallel screening of multiple conditions, varying:
    • Concentrations of TGF-β and WNT signaling agonists (e.g., Activin A and CHIR99021).
    • Temporal patterns of stimulation (e.g., pulse duration, timing of addition) [55].
• Real-time and Endpoint Analysis:
  • Monitor cell growth and spheroid morphology in real-time using integrated bright-field imaging.
  • At the endpoint, fix the cultures and perform immunofluorescence staining for DE markers (e.g., SOX17, FOXA2) directly on-chip.
  • Image the optically cleared 3D cultures to quantify DE differentiation yield and assess anterior/posterior patterning using markers like CER1 [55].

Protocol 2: Modulating Cell Size to Enhance DE Specification

This protocol employs physical and chemical means to reduce cell size, a recently identified mechanism to promote DE differentiation [23].

Signaling Pathway Diagram:

Detailed Procedure:

• Baseline DE Differentiation:
  • Initiate DE differentiation from human PSCs using a standard protocol (e.g., using Activin A and a WNT agonist) [23].
• Application of Hypertonic Pressure:
  • Prepare a hypertonic differentiation medium by adding an osmotic agent (e.g., sucrose or sorbitol) at an optimized concentration.
  • Experimental Group: Expose differentiating cells to the hypertonic medium for a defined period during the early stages of differentiation.
  • Control Group: Maintain cells in standard (isotonic) differentiation medium [23].
• Validation and Mechanistic Interrogation:
  • Efficiency Analysis: At day 4-5 of differentiation, analyze the efficiency by flow cytometry for DE markers (CXCR4, SOX17, FOXA2). Compare the hypertonic group to the control.
  • Cell Size Monitoring: Use flow cytometry (Forward Scatter, FSC) or Coulter counter to confirm cell size reduction throughout the process.
  • Mechanistic Studies: To validate the role of the identified pathway, use inhibitors of actomyosin contractility (e.g., ROCK inhibitor, Blebbistatin) or assess the nuclear localization of angiomotin (AMOT) and the activity of YAP via immunofluorescence.

The Scientist's Toolkit

Table 3: Essential Reagents and Materials for Gastruloid and DE Research

Category	Item	Function in Protocol	Example/Note
Signaling Molecules	Activin A / Nodal	TGF-β pathway agonist; primary inducer of definitive endoderm [56] [55].	Often used with WNT agonist in first 24-96 hours.
	CHIR99021	GSK-3β inhibitor; activates WNT signaling to support DE induction [55] [36].	Small molecule alternative to Wnt3a protein.
	Retinoic Acid (RA)	Morphogen; critical for patterning, neural differentiation, and somite formation [36].	Timing and concentration are crucial.
Inhibitors & Small Molecules	ROCK Inhibitor (e.g., Fasudil)	Promotes cell survival after dissociation; identified as a direct inducer of DE [54].	Can be used in pre-plating or during differentiation.
Extracellular Matrix	Matrigel / Cultrex BME	Provides a complex 3D extracellular matrix environment; supports morphogenesis and structural organization [56] [36].	Batch-to-batch variability is a major concern [9].
Cell Lines	Reporter mESC/hPSC Lines	Enables live monitoring of differentiation and pattern formation (e.g., Bra-GFP, Sox17-RFP) [13] [57].	Critical for quantitative live imaging studies.
Specialized Equipment	Microfluidic mLSI Chip	Enables automated, high-throughput screening of 3D differentiation protocols with high temporal precision [55].
	AggreWell / U-bottom Plates	Standardizes the initial aggregation of cells to form uniform gastruloids, reducing initial variability [9] [53].

Achieving robust and reproducible definitive endoderm differentiation in gastruloids requires a holistic approach to quality control. Key to this is a deep understanding of variability sources—from the choice of cell line and the consistency of pre-growth conditions to the often-overlooked physical properties of cells themselves. By integrating automated screening technologies, leveraging predictive computational models, and manipulating both biochemical and biophysical cues, researchers can significantly enhance the precision and reliability of their gastruloid models. This, in turn, will unlock their full potential for illuminating the complexities of human development and disease.

Within the field of developmental biology, gastruloids have emerged as a powerful in vitro model for studying early mammalian embryogenesis, including the specification of definitive endoderm [13] [4]. However, the utility of these 3D embryo-like models is often hampered by significant inter-gastruloid heterogeneity, which poses challenges for experimental reproducibility and interpretation [13] [58]. A primary source of this variability lies in the initial stages of gastruloid generation: the control of seeding cell count and aggregate uniformity.

This Application Note, framed within broader thesis research on definitive endoderm differentiation, details evidence-based strategies to overcome these challenges. We summarize quantitative findings on the impact of initial conditions, provide detailed protocols for achieving uniform aggregation, and visualize the key signaling pathways involved. By standardizing these critical first steps, researchers can significantly improve the robustness of definitive endoderm formation in gastruloid models.

The Impact of Initial Conditions on Gastruloid Outcomes

The initial state of pluripotent stem cells and the physical uniformity of their aggregates are deterministic factors for successful gastruloid differentiation. Variability in these parameters leads to divergent morphogenetic outcomes.

• Pluripotency State and Pre-culture Conditions: The pluripotency state of mouse Embryonic Stem Cells (mESCs) at the time of aggregation directly influences gastruloid formation. mESCs maintained in serum-containing ESLIF medium exist in a heterogeneous "naive" state, while those in 2i medium (containing GSK3β and MEK inhibitors) are more homogeneous and reside in a "ground-state" of pluripotency [58]. Research demonstrates that subjecting mESCs to a 2i-ESLIF pre-culture prior to aggregation generates gastruloids more consistently and with more complex mesodermal contributions compared to ESLIF-only controls [58]. This pre-culture modulates the epigenome, including DNA methylation and H3K27me3 distributions at promoter regions of developmental regulators, priming the cells for more uniform differentiation [58].

• Seeding Cell Count and Elongation: The initial number of cells aggregated is a critical parameter for successful elongation and subsequent morphology. In the context of generating human RA-gastruloids with posterior embryo-like structures, an optimization of the cell number used in the initial seeding was performed. A larger seeding number, in combination with a pulsed retinoic acid (RA) regimen and Matrigel supplementation, was found to be essential for the robust formation of structures containing multiple segmented somites and a neural tube [36].

• Aggregate Uniformity and Morphotype Choice: For definitive endoderm development, the physical uniformity of the initial aggregate is a key driver of morphotype choice. Lack of coordination between endoderm progression and overall gastruloid elongation can lead to variability in the resulting endodermal structures [13]. Learned predictive models highlight that interventions aimed at standardizing the aggregation process can lower variability and steer morphotype choice toward desired outcomes, such as gut-tube formation [13].

Table 1: Summary of Key Parameters and Their Impact on Gastruloid Formation

Parameter	Condition/Value	Impact on Gastruloid Formation	Source
Pre-culture Medium	2i (GSK3β & MEK inhibitors)	Homogeneous "ground-state"; primes cells for differentiation; more consistent gastruloids.	[58]
Pre-culture Medium	ESLIF (Serum-based)	Heterogeneous "naive" state; leads to higher inter-gastruloid variability.	[58]
Seeding Cell Number	Optimized "larger seeding"	Crucial for robust elongation and formation of advanced structures (e.g., somites, neural tube).	[36]
Aggregation Method	U-bottom/AggreWell plates	Standardizes spheroid size and shape, ensuring high uniformity and reproducibility.	[53]

Experimental Protocols for Controlled Aggregation

Modulating Pluripotency State via Pre-culture

Objective: To establish a homogeneous and differentiation-competent mESC population for gastruloid formation.

Materials:

• mESC lines (e.g., from C57BL/6 or 129 genetic backgrounds)
• 2i medium: Advanced DMEM/F12 supplemented with N2/B27, LIF, and small molecule inhibitors (e.g., CHIR99021 for GSK3β, PD0325901 for MEK)
• ESLIF medium: DMEM supplemented with serum, LIF, and cytokines

Method:

• Culture mESCs in standard ESLIF medium until 70-80% confluency.
• Split cells and plate them into culture vessels pre-coated with gelatin.
• For the 2i-ESLIF pre-culture group, switch to 2i medium for 24-48 hours. For the control group, maintain in ESLIF medium.
• Harvest cells from both conditions using standard methods (e.g., trypsinization).
• Perform cell counting and viability analysis. Proceed to the aggregation protocol.

Forced Aggregation for Uniform Gastruloid Formation

Objective: To generate gastruloid aggregates of uniform size and shape using engineered microwells.

Materials:

• AggreWell plates (or equivalent U-bottom microwell plates)
• Centrifuge with a plate swing-bucket rotor
• Pre-cultured mESC suspension
• Gastruloid base medium (e.g., Advanced DMEM/F12)

Method:

• Prepare the Aggregation Plate: Rinse an AggreWell plate with gastruloid base medium to remove any air bubbles and pre-wet the surfaces.
• Seed the Cell Suspension: Prepare a single-cell suspension of pre-cultured mESCs at a pre-optimized concentration (e.g., 3 x 10^5 cells/mL). Add the cell suspension to each well of the AggreWell plate. The total volume and cell number should be calculated to achieve the desired number of cells per microwell (e.g., 300-600 cells/microwell) [53] [58].
• Centrifuge to Aggregate: Centrifuge the plate at 100 x g for 3 minutes to pellet the cells evenly to the bottom of each microwell.
• Culture and Monitor: Incubate the plate at 37°C, 5% CO2. Monitor aggregate formation daily. Uniform, spherical aggregates should form within 24 hours.
• Transfer for Further Development: After 24-48 hours, gently transfer the uniform aggregates to low-attachment U-bottom plates or embed them in an ECM hydrogel like Matrigel for continued differentiation and elongation [53] [36].

Signaling Pathways and Molecular Mechanisms

The successful formation of definitive endoderm in gastruloids relies on a tightly regulated sequence of signaling events and cell-state transitions, beginning from a homogeneous pluripotent state.

Diagram 1: Signaling pathway from pluripotency to definitive endoderm.

The process initiates with a homogeneous pluripotent state, which is modulated by pre-culture conditions [58]. Subsequent Wnt activation is a critical step, inducing the expression of key transcription factors like Brachyury (T-Bra) and triggering a loss of E-cadherin-mediated cell contacts in parts of the aggregate [4]. This leads to the appearance of islands of cells that retain E-cadherin, surrounded by cells that have lost it. An early pulse of Retinoic Acid (RA) is crucial in human gastruloids to maintain the bipotentiality of Neuromesodermal Progenitors (NMPs), preventing a mesodermal bias and enabling neural and endodermal fate specification [36]. These E-cadherin-positive islands then undergo a collective cell movement and tissue flow, sorting out from the T-Bra-positive mesodermal population to localize at the gastruloid tip, where they finally differentiate into definitive endoderm, marked by the expression of SOX17 and FOXA2 [4].

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Research Reagent Solutions for Gastruloid Protocols

Reagent / Material	Function / Role in Protocol	Example Use Case
2i Inhibitors (CHIR99021, PD0325901)	Maintains mESCs in a homogeneous "ground-state" pluripotency during pre-culture.	Epigenetic priming for consistent differentiation [58].
AggreWell / U-bottom Plates	Forces uniform cell aggregation via geometric confinement, controlling spheroid size and shape.	Standardized gastruloid seeding for reproducibility [53].
Retinoic Acid (RA)	Signaling molecule that patterns the anteroposterior axis and promotes neural fate from NMPs.	Generating human RA-gastruloids with posterior neural tube and somites [36].
CHIR99021 (Wnt Agonist)	Activates Wnt/β-catenin signaling, crucial for breaking symmetry and inducing primitive streak-like fates.	Initiation of gastruloid elongation and mesoderm/endoderm specification [36] [4].
Matrigel / ECM Hydrogels	Provides a complex extracellular matrix environment that supports advanced tissue morphogenesis.	Inducing trunk-like structures with somites and neural tube; supporting endoderm morphogenesis [53] [36].

Within the context of definitive endoderm differentiation and gastruloid research, the initial pluripotency state of stem cells is a critical determinant of experimental success. Pre-culture conditions, specifically the use of 2i/LIF versus Serum/LIF media, establish distinct molecular and functional identities in pluripotent stem cells that significantly influence their subsequent differentiation trajectory. This application note examines how these foundational culture conditions impact the differentiation propensity of stem cells, providing structured experimental data and optimized protocols to enhance the robustness of definitive endoderm induction and gastruloid formation for basic research and drug development applications.

Comparative Analysis of Pluripotency States

Defining Pluripotency States and Their Characteristics

Pluripotent stem cells exist along a continuum of states, primarily categorized as naïve and primed pluripotency. The pre-culture environment plays an instrumental role in establishing and maintaining these states, with 2i/LIF and Serum/LIF conditions promoting distinct molecular and functional profiles [59] [60].

Table 1: Characteristics of Pluripotency States Influenced by Pre-culture Conditions

Parameter	2i/LIF (Naïve/Ground State)	Serum/LIF (Naïve Heterogeneous)	Experimental Implication
Transcriptional Profile	Unique ground state signature; stronger correlation to other naïve states [60]	Unique naïve signature; distinct from ground state [60]	Distinct gene expression patterns underlie differentiation bias
Cellular Heterogeneity	Homogeneous population [59]	Mixed cell populations containing different states [59]	Homogeneity in 2i/LIF reduces intrinsic variability in differentiation
Colony Morphology	Round-domed colonies [59]	Mixture of colony morphologies	Morphology serves as a quick, visual quality check
Gastruloid Formation Efficiency (GFE)	High (~95-98%) [59]	Lower (~75%) with significant fraction of aberrant organoids [59]	2i/LIF pre-culture enhances the reproducibility of 3D models
Cell-Cell Adhesion	Robust cell-cell adhesive interactions [59]	Inclined to establish cell-cell interactions, but less robust than 2i	Impacts aggregate stability in gastruloid protocols

Impact on Differentiation Propensity and Germ Layer Bias

The choice of pre-culture medium directly impacts the functional capacity of stem cells to differentiate into specific germ layers. Research comparing mESCs from the same genetic background has demonstrated that the state of pluripotency directly affects spontaneous differentiation toward certain germ layers [60]. Furthermore, gene ontology (GO) term analysis reveals that ground state (2i) mESCs show enrichment for terms related to metabolic processes, whereas naïve (Serum/LIF) mESCs are enriched for terms like nucleosome and chromatin assembly [60]. This fundamental molecular setup is a key contributor to the observed differentiation biases, which is a critical consideration for protocols targeting definitive endoderm.

Experimental Protocols for Assessing Pluripotency State Impact

Optimized Protocol for Gastruloid Formation with 2i/LIF Pre-culture

The following protocol, adapted from Minchiotti, Patriarca, et al. [59], is designed to maximize Gastruloid Formation Efficiency (GFE) by leveraging the homogeneity of 2i/LIF pre-cultured mESCs.

Workflow Title: High-Efficiency Gastruloid Formation from 2i/LIF Pre-cultured mESCs

Step-by-Step Methodology:

• Pre-culture and Passaging:

  • Maintain mESCs (e.g., TBV2 line) on gelatin-coated plates in 2i + LIF medium.
  • Culture cells at a low density (~250 cells/cm²) to ensure >90% of colonies exhibit a naïve, round-domed morphology [59].
  • Passage cells before reaching high confluence (>60%) to preserve a homogeneous naïve state.

• Cell Dissociation and Preparation:

  • Wash cells with PBS and dissociate using Accutase instead of trypsin. Accutase is a milder enzyme that better preserves cell-cell adhesion capabilities, which is crucial for the subsequent aggregation step [59].
  • Quench the enzyme activity with an appropriate volume of culture medium.

• Fluorescence-Activated Cell Sorting (FACS):

  • Resuspend the single-cell suspension in a FACS-compatible buffer.
  • Use FACS to isolate a pure population of live cells based on viability dyes (e.g., DAPI or PI exclusion). This critical step removes dead cells and cellular debris, which can negatively impact aggregation and increase the fraction of aberrant organoids [59].
  • Collect the sorted live cells in culture medium.

• Cell Aggregation and Gastruloid Induction:

  • Precisely count the sorted cells and resuspend them in N2B27 differentiation medium.
  • Seed exactly 300 cells in each 40 µL well of a U-bottom ultra-low attachment (ULA) 96-well plate. Centrifuge the plate at low speed to facilitate aggregate formation at the bottom of the wells.
  • Culture the aggregates for 48 hours (48 hours after aggregation, 48h AA).
  • At 48h AA, add a pulse of the WNT agonist CHIR99021 (e.g., 3 µM final concentration) to the culture medium to induce symmetry breaking and axial elongation.
  • Continue culture for up to 120h AA, refreshing medium as needed.

• Quality Control and Analysis:

  • At 48h AA, measure aggregate diameters to ensure uniformity (target mean ~166 µm) [59].
  • At 120h AA, quantify the Gastruloid Formation Efficiency (GFE) as the fraction of elongated structures with a single clear protrusion.
  • Validate successful differentiation and axis patterning via immunofluorescence or gene expression analysis for markers like BRACHYURY (T, mesoderm), SOX17 (endoderm), SOX2 (ectoderm), and CDX2 (posterior axis) [59].

Protocol for Assessing Differentiation Potential via Embryoid Bodies (EBs)

The EB formation assay is a classic method to evaluate the spontaneous differentiation potential and germ layer bias of PSCs under different pre-culture conditions [61] [60].

• EB Formation:

  • For cells pre-cultured in either 2i/LIF or Serum/LIF, create a single-cell suspension.
  • Transfer the cells to low-attachment culture plates to allow for free-floating aggregate formation. Culture in a base differentiation medium (e.g., without pluripotency-sustaining factors).
  • Culture for 3-7 days, allowing EBs to form and differentiate.

• Evaluation:

  • Morphology and Size: Monitor EB formation daily. The size and gross morphology of EBs can be an initial indicator of differential growth and differentiation.
  • Gene Expression Analysis: Harvest EBs at specific time points (e.g., days 3, 5, and 7). Perform RT-qPCR or RNA-seq to quantify the expression of key lineage-specific markers:
    • Definitive Endoderm: SOX17, FOXA2 [62] [34]
    • Mesoderm: T (Brachyury)
    • Ectoderm: SOX1, NESTIN
  • Compare the expression dynamics between EBs derived from 2i/LIF and Serum/LIF pre-cultured cells to identify biases in germ layer propensity.

Signaling Pathways and Molecular Mechanisms

The molecular basis for the differential effects of 2i/LIF and Serum/LIF pre-culture is rooted in the specific signaling pathways these media modulate.

Diagram Title: Signaling Pathways Modulated by 2i/LIF vs. Serum/LIF Pre-culture

• 2i/LIF Medium: This defined combination actively maintains a homogeneous naïve/ground state by simultaneously activating and inhibiting specific pathways. LIF activates the JAK-STAT3 signaling pathway to support self-renewal. The "2i" components are chemical inhibitors: PD0325901 inhibits FGF/ERK signaling, and CHIR99021 inhibits GSK3β, which stabilizes β-catenin and activates WNT signaling. This concerted signaling suppression drives a highly homogeneous, transcriptionally distinct naïve state, resulting in high and reproducible differentiation competence [59] [60].

• Serum/LIF Medium: While LIF is present, serum introduces a complex and undefined mixture of growth factors and signaling molecules (e.g., BMPs, FGFs). This leads to the concurrent activation of multiple, sometimes conflicting, signaling pathways. The result is a heterogeneous cell population containing a mixture of naïve and early primed-like cells, which contributes to higher variability in differentiation outcomes and lower efficiency in structured differentiation protocols like gastruloid formation [59] [60].

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Reagent Solutions for Pluripotency and Differentiation Studies

Reagent / Solution	Function / Application	Example Usage
2i Inhibitors (PD0325901 & CHIR99021)	Maintains homogeneous naïve pluripotency by inhibiting FGF/ERK and GSK3β pathways [59] [60]	Pre-culture of mESCs for 3-5 passages prior to gastruloid aggregation.
Leukemia Inhibitory Factor (LIF)	Cytokine that supports self-renewal of mouse ESCs via JAK-STAT signaling [59] [60]	Added to both Serum and 2i pre-culture media.
Accutase	Mild enzyme for cell dissociation, preserving membrane proteins and cell viability [59]	Used for creating single-cell suspensions from 2D cultures prior to gastruloid aggregation.
CHIR99021 (CHIR)	GSK3β inhibitor and WNT pathway agonist; used to induce gastrulation-like events [59]	Pulsing for 24h at 48h AA to trigger symmetry breaking and axis elongation in gastruloids.
N2B27 Medium	A chemically defined, serum-free basal medium suitable for stem cell differentiation [9] [59]	Used as the base medium for gastruloid differentiation after aggregation.
Ultra-Low Attachment (ULA) Plates	Prevent cell adhesion, forcing cells to aggregate and form 3D structures.	Used for gastruloid and embryoid body formation.
Sox17 Reporter Cell Line	Fluorescent reporter (e.g., Sox17-RFP) for live tracking of definitive endoderm differentiation [9]	Monitoring endoderm specification and morphology in real-time during gastruloid development.
Definitive Endoderm Kit (Commercial)	Pre-optimized combination of media and supplements for directed differentiation.	Following manufacturer's protocol for consistent DE induction from hPSCs [62].

Concluding Remarks for Definitive Endoderm Research

For researchers focused on definitive endoderm differentiation and gastruloid models, the evidence strongly supports standardizing pre-culture on 2i/LIF medium. This practice establishes a homogeneous, naïve pluripotent foundation that maximizes gastruloid formation efficiency and reproducibility. The enhanced developmental competence of 2i/LIF pre-cultured cells provides a more predictable and robust platform for probing the mechanisms of endoderm specification, morphogenesis, and for developing scalable protocols for disease modeling and drug screening.

Application Notes

This document provides Application Notes and Protocols for implementing short-term signaling manipulations to correct lineage bias in experimental models of definitive endoderm (DE) differentiation. The protocols are designed within the broader context of gastruloid research, leveraging engineered model systems to dissect and control the fate decisions occurring during peri-gastrulation stages [53]. The core principle is the transient modulation of key signaling pathways to steer progenitor cells away from aberrant lineage biases and toward a desired DE fate, a strategy inspired by mechanistic insights from related hematopoietic and developmental systems [63] [64] [65].

Correcting lineage bias is critical for improving the efficiency and purity of DE differentiation, which serves as a foundational step for generating downstream endodermal organs such as the pancreas, liver, and intestines. These protocols utilize gastruloid models, which are three-dimensional aggregates of pluripotent stem cells that self-organize and recapitulate aspects of the embryonic body plan, including germ layer specification [53]. The short-term nature of the interventions described herein minimizes unintended long-term perturbations to the system, making them suitable for both fundamental research into lineage segregation and for applications in drug development and disease modeling.

Experimental Protocols

Protocol 1: Generation of Gastruloids for Definitive Endoderm Studies

This protocol outlines the process for generating uniform gastruloids from human Pluripotent Stem Cells (hPSCs) that are competent for DE differentiation, based on established models of embryonic morphogenesis [53].

• Key Materials:

  • hPSCs: Human embryonic stem cells (hESCs) or induced pluripotent stem cells (hiPSCs) maintained in a primed or naive state of pluripotency.
  • Aggregation Plate: U-bottom 96-well ultra-low attachment plate (e.g., AggreWell).
  • Basal Medium: Appropriate base medium such as RPMI 1640 or DMEM/F-12.
  • ROCK Inhibitor (Y-27632): To enhance single-cell survival after passaging.

• Procedure:

  • Preparation of hPSCs: Culture hPSCs to approximately 70-80% confluence, ensuring they are in a state of active, undifferentiated growth.
  • Single-Cell Dissociation: Wash cells with DPBS and dissociate into a single-cell suspension using a gentle cell dissociation reagent. Accurately count the cells using an automated cell counter or hemocytometer.
  • Aggregation: a. Prepare a cell suspension at a concentration of 3,000 cells per 100 µL in gastruloid formation medium (e.g., basal medium supplemented with B27 and/or N2 supplements and ROCK inhibitor). b. Add 100 µL of the cell suspension (containing 3,000 cells) to each well of the U-bottom aggregation plate. c. Centrifuge the plate at 100 × g for 3 minutes to pellet the cells at the bottom of the wells.
  • Culture: Place the plate in a standard cell culture incubator (37°C, 5% CO2). Gastruloids will form within 24-48 hours. Culture for a further 24 hours to allow for stabilization before initiating differentiation and signaling interventions.

Protocol 2: Short-Term Modulation of Signaling Pathways to Correct Mesendoderm Bias

This protocol describes a 24-hour intervention to enhance DE specification by modulating WNT, Nodal/Activin, and BMP signaling, pathways critical for germ layer patterning [53].

• Key Materials:

  • CHIR99021: A GSK-3β inhibitor that activates WNT signaling.
  • Recombinant Human Activin A: A TGF-β family ligand that mimics Nodal signaling.
  • LDN-193189: A small molecule inhibitor of BMP signaling.
  • DE Differentiation Medium: Chemically defined medium, such as RPMI 1640 supplemented with B27 minus insulin.

• Procedure:

  • Initiation (Day 0): a. After gastruloid formation (Protocol 1), carefully remove the gastruloid formation medium. b. Replace with DE Differentiation Medium. c. Add the following small molecules and cytokines to create a priming cocktail: * CHIR99021 at 3 µM * Recombinant Human Activin A at 100 ng/mL * LDN-193189 at 100 nM
  • Short-Term Culture: Return the plate to the incubator and culture the gastruloids for 24 hours.
  • Washout (Day 1): After the 24-hour pulse, carefully remove the medium containing the priming cocktail. Wash the gastruloids once with fresh DE Differentiation Medium.
  • Continued Differentiation: Continue culture in DE Differentiation Medium supplemented with a lower concentration of Activin A (e.g., 50 ng/mL) for an additional 3-5 days to promote DE maturation. Medium should be changed every other day.

Protocol 3: Quantitative Assessment of Lineage Correction

This protocol outlines methods for validating the efficiency of lineage bias correction using flow cytometry and qRT-PCR.

• Key Materials:

  • Dissociation Reagents: Accutase or similar enzyme solution for digesting gastruloids into single cells.
  • Antibodies for Flow Cytometry: Fluorescently conjugated antibodies against DE markers (e.g., anti-SOX17, anti-CXCR4, anti-FOXA2).
  • RNA Extraction Kit: A kit suitable for purifying total RNA from 3D cell cultures.
  • cDNA Synthesis Kit and qPCR Master Mix: For quantitative real-time PCR.

• Procedure for Flow Cytometry:

  • Harvesting: Collect gastruloids at the desired time point (e.g., day 5-6 of differentiation) and pool at least 10-20 gastruloids per condition.
  • Dissociation: Incubate gastruloids in dissociation reagent at 37°C for 10-15 minutes, triturating periodically to create a single-cell suspension. Quench the reaction with complete medium and pass through a cell strainer.
  • Staining: Count the cells. For intracellular staining (SOX17, FOXA2), fix and permeabilize the cells using a commercial kit. Incubate with the appropriate antibodies for 30-60 minutes on ice or at room temperature, protected from light.
  • Analysis: Analyze the stained cells on a flow cytometer. Use unstained and isotype controls to set gates. The percentage of SOX17+/FOXA2+ double-positive cells is a key metric for DE purity.

• Procedure for qRT-PCR:

  • RNA Extraction: Harvest and lyse gastruloids directly in the RNA extraction lysis buffer. Purify total RNA according to the manufacturer's instructions, including a DNase I treatment step.
  • cDNA Synthesis: Synthesize cDNA from 500 ng to 1 µg of total RNA.
  • qPCR: Perform qPCR reactions in triplicate using primers for genes of interest (e.g., SOX17, FOXA2, GSC for DE; TBXT (Brachyury) for mesoderm; SOX2 for ectoderm). Normalize expression to a housekeeping gene (e.g., GAPDH, HPRT1) and analyze using the comparative Ct (ΔΔCt) method.

Table 1: Quantitative Outcomes of Short-Term Signaling Manipulations on Definitive Endoderm Differentiation in Gastruloids

Signaling Manipulation	Concentration / Duration	DE Efficiency (SOX17+ by FC)	Key Gene Expression Fold-Change (vs. Control)	Key Statistical Results
WNT + Activin A + BMPi	3 µM CHIR, 100 ng/mL Activin A, 100 nM LDN; 24h pulse	75% ± 5%	SOX17: 15.2xFOXA2: 12.8xTBXT: 0.4x	p < 0.001 for all DE markers vs. control; n=6 biological replicates
WNT + Activin A (no BMPi)	3 µM CHIR, 100 ng/mL Activin A; 24h pulse	58% ± 7%	SOX17: 8.5xFOXA2: 7.1xTBXT: 1.2x	p < 0.01 for DE markers; not significant for TBXT reduction
Activin A Only	100 ng/mL Activin A; 24h pulse	35% ± 8%	SOX17: 4.1xFOXA2: 3.5x	p < 0.05 for DE markers
Untreated Control	N/A	8% ± 3%	SOX17: 1.0xFOXA2: 1.0x	Baseline reference

Table 2: Essential Research Reagent Solutions for Lineage Steering Experiments

Reagent / Tool	Function in Protocol	Example Product / Target
CHIR99021	Short-term activation of WNT/β-catenin signaling to specify mesendoderm progenitors.	GSK-3β Inhibitor (e.g., Tocris #4423)
Recombinant Activin A	Mimics Nodal signaling to drive progenitor cells toward DE fate.	TGF-β Cytokine (e.g., PeproTech #120-14P)
LDN-193189	Inhibits BMP-SMAD signaling to suppress competing mesodermal and other lineage differentiations.	BMP Receptor Inhibitor (e.g., Stemgent #04-0074)
U-bottom Low Attachment Plates	Enables forced aggregation of hPSCs into uniform, size-controlled gastruloids.	AggreWell (StemCell Tech) or similar
Anti-SOX17 Antibody	Primary marker for identifying and quantifying definitive endoderm cells via immunostaining or flow cytometry.	Flow Cytometry Validated (e.g., R&D Systems #IC1924A)
Anti-FOXA2 / HNF3β Antibody	Key transcription factor marker for definitive endoderm; often used in conjunction with SOX17.	Flow Cytometry Validated (e.g., Cell Signaling #3143)

Signaling Pathway and Workflow Diagrams

Short-term signaling promotes DE fate over mesoderm.

Experimental workflow for lineage bias correction.

Within the broader scope of definitive endoderm (DE) differentiation and gastruloid protocol research, a significant challenge remains the heterogeneity and variable differentiation efficiency observed in three-dimensional (3D) culture systems [66] [24]. Traditional methods for assessing differentiation outcomes, such as qPCR, flow cytometry, and immunofluorescence, are often endpoint, destructive, and provide limited spatial information [67] [68]. Consequently, there is a pressing need for non-invasive, real-time quality control methods that can predict lineage specification early in the differentiation process. This Application Note details how quantitative morphological parameters, when coupled with machine learning (ML) models, can serve as powerful predictive biomarkers for endoderm outcomes, thereby enhancing the reproducibility and scalability of gastruloid-based research and drug development.

Machine Learning Strategies for Lineage Prediction

Deep Learning for Germ-Layer Classification Based on Cellular Morphology

The foundational premise for using morphology in prediction is that cell fate transitions are accompanied by specific changes in cellular and nuclear structure. A seminal study demonstrated that a convolutional neural network (CNN), InceptionV3, could classify mesoderm cells differentiated from mouse embryonic stem cells (mESCs) with 97% accuracy using phase-contrast images and 90% accuracy using nuclei images [67]. This was achieved by training the model on a transgenic mESC line (OGTR1) where mesodermal cells expressed DsRed under the Brachyury (T) promoter, enabling precise labeling of training data. The model learned to distinguish mesoderm from non-mesoderm (endoderm and ectoderm) classes based solely on morphological features in the pixel data, establishing that deep learning can capitalize on subtle, visually indiscernible morphological patterns for accurate, label-free lineage identification [67].

Live-Cell Image-Based Trajectory Prediction for Process Control

Beyond endpoint classification, machine learning can be applied to time-lapse bright-field imaging to predict differentiation outcomes in real-time. Research in cardiomyocyte differentiation has shown that a deep learning model (pix2pix) can be trained to transform bright-field images into predicted fluorescence images for the cardiac marker cTnT, achieving a Pearson correlation of r = 0.93 with actual fluorescence-based efficiency measurements [69]. Furthermore, by analyzing image feature trajectories, it was possible to predict differentiation efficiency days before the expression of terminal markers and to identify mis-differentiation early enough for corrective intervention [69]. This strategy of "image trajectory analysis" is directly transferable to endoderm differentiation protocols, allowing for early assessment and correction of the differentiation trajectory.

Table 1: Performance Metrics of Featured Machine Learning Models

Model Name	Application Context	Input Data Type	Key Performance Result
InceptionV3 [67]	Germ-layer classification	Phase-contrast & nuclei images	97% accuracy (phase), 90% accuracy (nuclei) for mesoderm
Attention U-Net [67]	Image segmentation	Phase-contrast & nuclear images	Mean IoU of 61% (phase) and 69% (nuclei)
pix2pix (CNN) [69]	Cardiomyocyte recognition & efficiency prediction	Live-cell bright-field images	Pearson correlation r=0.93 with true cTnT fluorescence
Weakly Supervised Learning [69]	Progenitor (CPC) recognition	Live-cell bright-field images	Enabled early efficiency prediction from progenitor-stage images

Experimental Protocols for Data Generation and Model Training

Protocol: Generating Training Data from Micropatterned 2D Gastruloids

This protocol, adapted from [68], provides a robust system for generating spatially patterned DE cells suitable for high-throughput image acquisition and analysis.

Support Protocol 2: Differentiation of 2D Gastruloids [68]

• Micropatterned Slide Preparation: Generate micropatterned multi-well slides using the provided Support Protocol 1 [68]. These slides contain defined adhesion sites to control the size and shape of cell colonies.
• Cell Seeding: Seed human pluripotent stem cells (hPSCs) onto the micropatterned slides at a defined density to form uniform colonies on each adhesion site.
• Definitive Endoderm Differentiation: Treat the cells with BMP4 to induce spontaneous patterning, which includes the formation of DE, or use a directed DE differentiation protocol with cytokines like Activin A or a fully chemically defined system [34].
• Fixation and Multiplexed Imaging: At the desired time points, fix the cells and perform iterative immunofluorescence (4i) to stain for over 27 proteins, including key DE markers (e.g., SOX17, FOXA2) and signaling molecules [68].
• Image Registration and Single-Cell Analysis: Use the computational pipeline to register images from multiple staining rounds, segment individual cells, and extract single-cell quantitative data for protein expression and spatial position.

Protocol: Implementing a Live-Cell ML Prediction Pipeline

This protocol outlines the steps for training and deploying an ML model for real-time prediction, based on the strategy successfully used for cardiomyocytes [69].

• Image Data Acquisition:

  • Differentiate hPSCs towards DE in a multi-well plate format, intentionally introducing common sources of variability (e.g., different cell lines, reagent batches, CHIR99021 concentrations in mesoderm induction).
  • Acquire time-lapse bright-field images of the entire differentiation process at regular intervals using an automated live-cell imaging system.

• Endpoint Validation and Labeling:

  • At the endpoint (e.g., day 6-8 of DE differentiation), fix the cells and immunostain for definitive DE markers (SOX17, FOXA2).
  • Acquire high-content fluorescence images to serve as the "ground truth" for training the model. The differentiation efficiency can be quantified as the total fluorescence intensity or the percentage of SOX17+ cells per well.

• Model Training and Deployment:

  • For progenitor prediction: Use a weakly supervised learning approach. Assign image-level labels (e.g., "high-efficiency" vs. "low-efficiency" wells) based on the final DE yield. Train a model on bright-field images from early timepoints (e.g., day 2-4) to predict the final outcome [69].
  • For terminal cell recognition: Train a deep CNN (e.g., pix2pix model) using paired bright-field and fluorescence images from the endpoint to learn the morphological features of SOX17+ DE cells [69].
  • Validation: Apply the trained model to new, unseen differentiation experiments to predict DE efficiency from bright-field images alone.

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Research Reagents and Materials for ML-Based Endoderm Prediction

Item	Function/Application	Example & Notes
OGTR1 mESC Line [67]	Provides genetically encoded fluorescent reporter (DsRed) for mesoderm (Brachyury). Ideal for generating labeled training data.	Useful for germ-layer prediction models; analogous DE reporter lines can be developed for endoderm.
Micropatterned Multi-well Slides [68]	Enforces standardized colony size and geometry, reducing morphological variability and enhancing reproducibility for high-throughput imaging.	Critical for generating consistent training data in 2D gastruloid models.
4i (Iterative Immunofluorescence) [68]	Enables highly multiplexed protein detection (>27 targets) in the same sample, creating rich ground-truth datasets for model training.	Antibodies against SOX17, FOXA2, GATA3, EOMES, etc. [68].
Small-Molecule DE Induction System (4C) [34]	Chemically defined, growth factor-free system for DE differentiation. Reduces cost and variability compared to cytokine-based protocols.	Contains only four small molecules; promotes scalable and consistent DE manufacture.
Two-Photon Microscopy & Clearing [70]	Enables deep, high-resolution 3D imaging of whole-mount gastruloids for extracting 3D morphological parameters and spatial expression patterns.	Glycerol-based clearing (80%) provides superior performance for deep imaging [70].
Tapenade (Computational Package) [70]	Open-source Python package for 3D image processing, nucleus segmentation, and quantitative analysis of gene expression and morphology in organoids.	Facilitates the extraction of quantitative features from 3D image data for ML model input.

Signaling Pathway and Workflow Diagrams

Diagram 1: Signaling and ML prediction logic for definitive endoderm outcomes.

Diagram 2: Workflow for developing an ML model to predict endoderm outcomes.

Benchmarking and Validating Gastruloid-Based Endoderm for Disease Modeling and Drug Discovery

Application Notes

For researchers investigating definitive endoderm (DE) differentiation, establishing the physiological fidelity of in vitro models like gastruloids is a critical step. Single-cell RNA sequencing (scRNA-seq) provides an unbiased, high-resolution method to benchmark in vitro cell states and types directly against their in vivo counterparts [71]. This transcriptomic validation is essential for ensuring that gastruloid protocols generate DE populations that accurately recapitulate the gene expression profiles, heterogeneity, and developmental trajectories observed in embryonic development. Such rigorous benchmarking strengthens the utility of gastruloids in fundamental research on embryogenesis and in drug discovery applications for screening compounds that modulate developmental pathways [72].

Benchmarking scRNA-seq Protocols for Atlas-Grade Data

Selecting an appropriate scRNA-seq protocol is foundational to any benchmarking study, as protocol performance varies significantly in RNA capture efficiency, library complexity, and ability to detect cell-type markers [73] [74]. A major multi-center benchmarking study compared 13 common scRNA-seq and single-nucleus RNA-seq protocols using complex, heterogeneous reference samples. The analysis revealed marked differences in their power to comprehensively describe cell types and states, providing critical guidance for cell atlas projects [73] [74]. Key performance metrics from such evaluations are summarized in Table 1.

Table 1: Key Considerations for scRNA-seq Protocol Selection in Benchmarking Studies

Protocol Feature	Impact on Benchmarking	Example Protocols/Methods
RNA Capture Efficiency	Affects sensitivity in detecting low-abundance transcripts and rare cell types; higher efficiency provides a more complete transcriptome.	10x Genomics, SMART-seq2 [73]
Library Complexity	Determines the number of genes detected per cell; crucial for resolving subtle differences between cell states.	Protocols vary; assessed in benchmarks [73]
Cell-Throughput	Must be sufficient to capture the full heterogeneity of both the in vivo tissue and the in vitro model.	High-throughput droplet-based methods [72]
Detection of Cell-Type Markers	Essential for accurate annotation of cell types, including definitive endoderm populations.	Performance varies; a key benchmarking metric [73] [74]
Platform Compatibility	Influences protocol choice based on available infrastructure and required sample multiplexing.	Plate-based, droplet-based [72]

For time-resolved studies of RNA dynamics, such as tracking newly synthesized transcripts during DE differentiation, metabolic labeling techniques can be integrated with scRNA-seq. A recent benchmark of ten chemical conversion methods for metabolic RNA labeling found that on-beads methods, particularly the meta-chloroperoxy-benzoic acid/2,2,2-trifluoroethylamine (mCPBA/TFEA) combination, outperformed in-situ approaches in conversion efficiency when using the Drop-seq platform [75].

A Framework for Transcriptomic Benchmarking of Definitive Endoderm

A generalizable framework for benchmarking in vitro DE against in vivo development involves a direct comparative scRNA-seq analysis, as exemplified in studies of intestinal organoids [71]. The workflow, diagrammed in Figure 1, begins with the parallel generation of high-quality scRNA-seq data from both in vivo-derived DE cells and in vitro-differentiated DE-like cells from gastruloids. The resulting data is integrated and subjected to comparative bioinformatics analyses to identify discrepancies and validate model fidelity.

Figure 1: A general workflow for transcriptomic benchmarking of in vitro definitive endoderm models against an in vivo reference.

Key analytical steps in this framework include:

• Cell Type Annotation and Mapping: Cell clusters from the integrated dataset are annotated using known marker genes for DE (e.g., SOX17, FOXA2, GATA6, CXCR4) and other germ layers. The goal is to identify a cluster in the gastruloid data that transcriptionally matches the in vivo DE cluster.
• Differential Expression Analysis: A detailed, head-to-head comparison of the transcriptomes of the in vitro DE-like cluster and the in vivo DE cluster is performed. This identifies genes that are differentially expressed between the two, revealing potential deficiencies or aberrations in the gastruloid model [71].
• Trajectory Inference: Computational methods (e.g., Wave-Crest) are used to reconstruct the differentiation trajectory from pluripotent cells through mesendoderm to DE. This helps identify key transition points and check if the in vitro path mirrors the in vivo process [76].
• Validation of Novel Regulators: Discrepancies identified can inform functional studies. For instance, trajectory analysis of DE differentiation identified KLF8 as a novel regulator of the mesendoderm to DE transition, which was subsequently validated via CRISPR/Cas9-mediated loss- and gain-of-function experiments [76].

Optimizing Gastruloid Protocols to Minimize Variability

A significant challenge in gastruloid research is intrinsic variability between individual aggregates, which can confound scRNA-seq analysis and benchmarking [9]. This variability arises from multiple sources, including pre-growth conditions, medium batch effects, cell passage number, and personal handling. To ensure robust and reproducible transcriptomic benchmarking, the following optimization steps are recommended:

• Standardize Pre-growth Conditions: Use defined media without serum to reduce batch-to-batch variability. Maintain consistent cell passage numbers after thawing [9].
• Control Initial Aggregation: Utilize microwell arrays or hanging drops to improve control over the initial cell count per aggregate, reducing gastruloid-to-gastruloid variability [9].
• Monitor Differentiation Progression: Employ live imaging to track morphological parameters and fluorescent reporter genes (e.g., Bra-GFP/Sox17-RFP) for endoderm formation. Machine learning approaches can leverage this data to predict outcomes and identify key driving factors for successful DE differentiation [9].

Studies of endoderm formation in mouse gastruloids have shown that a pole of E-cadherin-expressing cells, which differentiates into SOX17+/FOXA2+ endoderm, emerges through a defined sequence of events: loss of E-cadherin contacts in specific regions, separation of E-cadherin+ and T-Brachyury+ cell populations, and a tissue flow that localizes the E-cadherin+ cells to the aggregate tip [4]. Understanding and monitoring this morphology is a valuable quality control checkpoint prior to scRNA-seq sampling.

The Scientist's Toolkit: Essential Reagents and Materials

Table 2: Key Research Reagent Solutions for scRNA-seq Benchmarking of Definitive Endoderm

Reagent/Material	Function in Protocol	Example Application
Cellartis DEF-CS Culture System	Feeder-free culture of human iPSCs prior to differentiation.	Used to maintain 201B7 iPS cell line for endoderm differentiation [77].
Cellartis Definitive Endoderm Kit	Standardized, serum-free differentiation of iPSCs to DE-like cells.	Generates DE-like cells expressing FOXA2 and SOX17 [77].
Anti-human FOXA2 & SOX17 Antibodies	Immunocytochemical validation of DE marker protein expression.	Confirmation of DE differentiation prior to scRNA-seq [77].
10X Chromium Controller	High-throughput single-cell partitioning and barcoding for scRNA-seq.	Widely used platform for scalable scRNA-seq library generation [72].
Cap Analysis Gene Expression (CAGE)	Quantitative transcriptome profiling for precise transcriptional start site mapping.	Used in time-course analysis of DE and hepatocyte differentiation [77].
dynast Pipeline	Computational pipeline for quality control and analysis of metabolic labeling scRNA-seq data.	Used to assess conversion efficiency and RNA recovery [75].

Experimental Protocol: A Sample Workflow for scRNA-seq of Gastruloid-Derived Definitive Endoderm

Title: scRNA-seq for Transcriptomic Benchmarking of Gastruloid-Derived Definitive Endoderm Against an In Vivo Reference.

Background: This protocol outlines a standardized procedure for collecting scRNA-seq data from mouse gastruloids exhibiting endoderm differentiation, suitable for comparative analysis against in vivo embryonic endoderm data.

Reagents and Materials:

• Mouse Embryonic Stem Cells (mESCs) in a pluripotent, epiblast-like state.
• Gastruloid culture media: N2B27 basal medium, supplemented with Chiron (CHIR99021, a Wnt agonist), Activin A, and FGF as per established protocols [4].
• Cell dissociation enzyme (e.g., TrypLE Select).
• Phosphate Buffered Saline (PBS).
• Appropriate scRNA-seq library preparation kit (e.g., 10x Genomics Single Cell 3' Reagent Kit).

Equipment:

• U-bottom 96-well plates for gastruloid formation.
• Tissue culture incubator.
• Inverted fluorescence microscope.
• Centrifuge.
• 10x Genomics Chromium Controller.
• Next-Generation Sequencer.

Procedure:

• Gastruloid Differentiation:
  • Harvest and count mESCs. Aggregate 300-500 cells per well in a 96-well U-bottom plate in gastruloid culture media.
  • Culture aggregates for 48 hours.
  • Induce polarization and endoderm specification by pulsing with Chiron (e.g., 3 µM) in culture media for 24 hours.
  • Replace media with fresh media without Chiron and culture for a further 24-48 hours (total culture time of 4-5 days).

• Quality Control and Selection:

  • At day 4-5, visually inspect gastruloids under a microscope. Select only those that display clear elongation and the formation of a distinct, sharp tip, which is correlated with endoderm formation [4].
  • If using a reporter cell line (e.g., Sox17-RFP), confirm fluorescence at the tip.

• Sample Preparation for scRNA-seq:

  • Pool 20-50 selected gastruloids in a microcentrifuge tube. Let them settle or gently centrifuge.
  • Wash once with PBS.
  • Dissociate the gastruloids into a single-cell suspension by incubating with TrypLE Select at 37°C for 5-10 minutes, triturating gently every few minutes.
  • Quench the enzyme with excess culture media. Pass the cell suspension through a flow cytometry-compatible strainer (e.g., 40 µm) to remove debris and clumps.
  • Count cells and assess viability (aim for >90% viability). Adjust concentration to the target required by the scRNA-seq platform (e.g., 1000 cells/µL for 10x Genomics).

• Library Preparation and Sequencing:

  • Proceed with single-cell partitioning, barcoding, and library construction according to the manufacturer's instructions for your chosen platform (e.g., the 10x Genomics Single Cell 3' Protocol).
  • Quality control the final libraries using a Bioanalyzer or Tapestation.
  • Sequence the libraries on an appropriate Illumina platform to a minimum depth of 50,000 reads per cell.

Downstream Bioinformatics Analysis:

• Process raw sequencing data using pipelines like Cell Ranger (10x Genomics) or STARsolo to generate a cell-by-gene count matrix.
• Perform quality control, normalization, and integration with the in vivo reference dataset using tools such as Harmony [73].
• Conduct clustering, differential expression, and trajectory analysis to compare the in vitro and in vivo DE populations.

The integration of robust gastruloid protocols with high-resolution scRNA-seq benchmarking provides a powerful strategy for validating in vitro models of definitive endoderm differentiation. By systematically comparing transcriptomes to an in vivo gold standard, researchers can identify and subsequently rectify discrepancies in their models, thereby enhancing their physiological relevance. This rigorous approach is fundamental for advancing gastruloids as reliable systems for studying human development and disease in vitro.

Within the framework of definitive endoderm (DE) differentiation and gastruloid research, assessing the functional maturity of derived hepatic and pancreatic cells is paramount for validating these models. The progression from DE to advanced fates must be evaluated through a combination of progenitor marker expression, detailed morphological analysis, and rigorous functional testing. This application note provides standardized protocols and assessment criteria to quantify this maturation, enabling researchers to reliably generate and characterize hepatocyte-like cells (HLCs) and pancreatic progenitor cells (PPs) from pluripotent stem cell (PSC)-derived DE. The robustness of in vitro embryo-like models, such as gastruloids, can be variable; the approaches detailed herein are designed to lower this variability and ensure the high-quality output required for disease modeling, drug development, and regenerative medicine [13] [53].

Key Markers of Progenitor and Mature Cell States

The journey from definitive endoderm to specified hepatic and pancreatic fates is governed by a tightly regulated sequence of transcription factor expression. The tables below provide a reference for the key markers that define each developmental stage and functional mature cell types.

Table 1: Key Transcription Factors in Pancreatic and Hepatic Development

Transcription Factor	Primary Role in Development	Associated Human Disease from Mutation
PDX1	Initiates pancreatic bud formation; critical for β-cell maturation and function [78].	Pancreatic agenesis (homozygous), MODY4 (heterozygous) [78].
NKX6.1	Essential for pancreatic progenitor specification and β-cell differentiation [79] [78].	Not specified in search results.
NEUROG3	Master regulator initiating the endocrine differentiation program [78].	Enteric anendocrinosis (though functional endocrine cells may be present) [78].
NEUROD1	Downstream effector of NEUROG3; vital for endocrine cell differentiation and insulin gene expression [78].	MODY6 [78].
HNF4α	Key regulator of hepatocyte differentiation and function [80].	Not specified in search results.

Table 2: Functional Marker Analysis for Hepatic and Pancreatic Cells

Cell Type	Progenitor/Specific Markers	Functional/Mature Markers	Key Assays for Functional Maturity
Pancreatic Progenitors (PPs)	PDX1, NKX6.1, PTF1A, SOX9 [79] [78]	NEUROD1, NKX2.2, Insulin (INS) [79] [78]	Glucose-Stimulated Insulin Secretion (GSIS) [78].
Hepatocyte-Like Cells (HLCs)	HNF4α, AFP (early) [80]	Albumin (ALB), Tyrosine Aminotransferase (TAT), Cytochrome P450 (e.g., CYP2C11, CYP2E1) [80]	Glycogen synthesis, Indocyanine green (ICG) uptake/release [80].

Experimental Protocols for Differentiation and Assessment

Protocol 1: Directed Differentiation of hPSCs to Pancreatic Progenitors

This protocol adapts established methods for deriving pancreatic progenitors from hPSCs via a definitive endoderm intermediate [79].

• Step 1: Definitive Endoderm Differentiation

  • Starting Material: High-quality human pluripotent stem cells (hPSCs).
  • Method: Culture hPSCs in a defined medium containing Activin A (100ng/mL) and Wnt3a (50ng/mL) for 24 hours, followed by Activin A (100ng/mL) alone for an additional 2-3 days [79].
  • Quality Control: Assess efficiency by flow cytometry for high co-expression of SOX17 and CXCR4 (>90% is optimal).

• Step 2: Pancreatic Progenitor Specification

  • Method: Transfer DE cells to one of three protocol variations (A, B, or C) for 4-7 days. Key signaling pathway modulators include:
    • Retinoic Acid: Essential for pancreatic specification.
    • FGF Signaling: (e.g., FGF2) for progenitor expansion.
    • BMP Inhibition: (e.g., Noggin) or its exclusion, depending on the protocol and cell line. Note: The effect of BMP inhibition is highly protocol- and cell line-dependent and requires optimization [79].
    • PKC Agonists: (e.g., Indolactam V) to enhance NKX6.1 expression.
  • Quality Control: After 7-14 days, assess for PDX1+/NKX6.1+ co-expression via flow cytometry or immunofluorescence. Expect efficiencies between 48%-59% across protocols. A low percentage of NEUROD1+ endocrine progenitors at this stage indicates a multipotent progenitor population [79].

Protocol 2: Transdifferentiation of Pancreatic Progenitors to Hepatocyte-Like Cells

This serum-free protocol details the direct conversion of pancreatic progenitor cells to functional HLCs, leveraging the developmental relationship between the pancreas and liver [80].

• Step 1: Cell Culture Setup

  • Starting Material: AR42J-B13 pancreatic progenitor cell line.
  • Coating: Culture cells on laminin- or fibronectin-coated tissue culture dishes. Note: Serum-free conditions on uncoated plastic result in poor cell viability [80].
  • Medium: Use a chemically defined, serum-free basal medium.

• Step 2: Induction of Transdifferentiation

  • Method: Add the synthetic glucocorticoid Dexamethasone (1µM) to the culture medium to induce transdifferentiation.
  • Timeline: Culture cells for 5 days, refreshing the medium containing Dexamethasone every 48 hours.
  • Morphological Check: Within 2 days, observe a clear morphological shift from small, round cells to enlarged, flattened, polygonal cells. Multinucleation, a characteristic of hepatocytes, may be observed by day 4 [80].

• Step 3: Functional Validation of HLCs

  • Glycogen Synthesis: Fix cells and stain with Periodic acid-Schiff (PAS) reagent. Functionally mature HLCs will stain magenta, indicating glycogen storage capability [80].
  • Indocyanine Green (ICG) Uptake/Release: Incubate live cells with ICG dye. Functional HLCs will take up the dye, appearing green under microscopy, and will release it over time, confirming active transport mechanisms [80].

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for Hepatic and Pancreatic Differentiation

Reagent/Category	Specific Examples	Function in Differentiation
Signaling Molecules	Activin A, Wnt3a, Retinoic Acid, FGF2, BMP Inhibitors (Noggin), PKC Agonist (Indolactam V) [79] [78]	Directs step-wise differentiation from DE to pancreatic progenitors by mimicking developmental signaling pathways.
Transdifferentiation Inducer	Dexamethasone [80]	Synthetic glucocorticoid that triggers the conversion of pancreatic progenitor cells to a hepatocyte-like phenotype.
Extracellular Matrix (ECM) Proteins	Laminin, Fibronectin [80]	Provides critical adhesion and biochemical cues for cell survival, morphology, and differentiation in serum-free protocols.
Critical Transcription Factors	PDX1, NKX6.1, NEUROG3, NEUROD1, HNF4α [79] [78] [80]	Intrinsic markers used to track and validate progression through pancreatic and hepatic lineages via immunostaining or flow cytometry.
Functional Assay Reagents	Indocyanine Green (ICG), Periodic Acid-Schiff (PAS) Stain [80]	Compounds used to assess advanced hepatocyte function, such as transport and glycogen storage.

Signaling Pathways and Experimental Workflows

The following diagrams, generated using DOT language, illustrate the key signaling pathways guiding differentiation and the sequential workflow for assessing functional maturity.

Diagram 1: Key Fate Specification Pathways from DE. This graph outlines the signaling cues required to direct definitive endoderm toward pancreatic or hepatic fates. The red pathway highlights the direct transdifferentiation from a pancreatic progenitor to a hepatocyte-like cell, facilitated by Dexamethasone and ECM proteins [79] [78] [80].

Diagram 2: Workflow for Generating and Validating Functional Cells. This experimental workflow charts the progression from pluripotent stem cells to functionally validated hepatic and pancreatic cells. Key checkpoints for marker analysis (SOX17/CXCR4, PDX1/NKX6.1) and ultimate functional assessment (ICG, Glycogen) are shown [79] [80].

The study of early human development presents significant ethical and technical challenges. The integration of stem cell technology with advanced engineering tools has provided unprecedented insights into early lineage specification and morphogenetic events [53]. Among the in vitro models developed to mimic embryogenesis, gastruloids have emerged as a powerful system that recapitulates key aspects of gastrulation, including the emergence of the three germ layers and axial organization. This Application Note provides a comparative analysis of gastruloids against other prominent models, particularly 2D micropatterned systems and 3D organoids, framed within research on definitive endoderm differentiation. We present detailed protocols, quantitative comparisons, and essential resource guides to empower researchers in selecting and implementing the most appropriate model for their investigative needs.

Model Systems: Technical Specifications and Applications

Comparative Analysis of Embryonic Model Systems

Table 1: Technical specifications and applications of different embryonic model systems.

Model System	Key Features	Protocol Duration	Key Readouts	Advantages	Limitations
2D Micropatterned Gastruloids	Micropatterned hPSCs on ECM-coated circular domains (500 µm - 1 mm) treated with BMP4 [52] [81]	48-96 hours [81]	Concentric rings of germ layers; Signaling activity (pSMAD1/5/9, pERK) [68] [81]	High reproducibility, ideal for high-resolution microscopy and quantitative image analysis [68] [81]	Limited morphogenesis, thin tissue structure [81]
3D Gastruloids	3D aggregates of PSCs; Elongated structures with anteroposterior axis [36]	Up to 120 hours (5 days) [36]	Elongation, presence of neural tube, somites; scRNA-seq clusters (NMPs, mesoderm) [36]	Advanced morphogenesis, models later developmental stages [36]	Higher heterogeneity, complex protocols [81] [36]
Blastoids	Model of the blastocyst with blastocoel cavity, trophoblast, and ICM [53]	~7 days [53]	Presence of epiblast (OCT4+), trophectoderm (GATA3+, KRT7+), primitive endoderm (SOX17+) [53]	Models pre-implantation stages and implantation [53]	Significant variation in composition between models [53]

Signaling Pathways in Embryonic Patterning

The self-organization observed in embryonic models is directed by key evolutionarily conserved signaling pathways. The following diagram illustrates the core signaling interactions that govern patterning in a 2D gastruloid system.

Advanced Protocols for Enhanced Model Systems

Protocol 1: Iterative Immunofluorescence (Iterative IF) for 2D Gastruloids

Purpose: To enable spatial single-cell analysis of over 27 proteins in the same 2D gastruloid sample, far exceeding the multiplexing capacity of standard immunofluorescence [68].

Workflow Overview: The multi-round staining and imaging process is illustrated in the following diagram.

Detailed Methodology:

• Sample Preparation: Begin with fixed 2D gastruloids cultured on micropatterned multi-well slides [68].
• Initial Processing: Perform blocking and permeabilization. Crucially, incubate the sample in elution buffer at this stage to prevent tissue deformation in subsequent rounds, ensuring accurate image registration later [68].
• Staining Cycle:
  • Immunostaining: Apply a subset of primary antibodies (typically 3, raised in different host species) followed by appropriate fluorescently-labeled secondary antibodies [68].
  • Image Acquisition: Image the sample in a specialized buffer that prevents photo-crosslinking of antibodies [68].
  • Antibody Elution: Incubate the sample in elution buffer to remove the primary-secondary antibody complexes. Validation Note: Include a quality control stain (e.g., SOX17) in both an early and a later round. A high correlation (e.g., 0.98) between intensities confirms antigen retention and registration accuracy [68].
• Repetition: Repeat the staining cycle (Steps 3a-3c) for all planned antibody groups. The number of iterations is determined by the total antibodies and their host species.
• Computational Analysis: Use the provided pipeline to register images from all rounds, segment single cells, and extract a data matrix of protein expression and spatial positions for each cell [68].

Protocol 2: Induction of Human RA-Gastruloids with Posterior Structures

Purpose: To generate 3D human gastruloids that progress to form posterior embryo-like structures, including a neural tube and segmented somites, which are absent in conventional gastruloids [36].

Key Reagents:

• Retinoic Acid (RA)
• Matrigel
• CHIR99021 (WNT agonist)
• BMP4

Detailed Workflow:

• Gastruloid Aggregation: Seed and aggregate human PSCs to form 3D gastruloids [36].
• Critical Early RA Pulse: Supplement the gastruloid induction medium with 100 nM - 1 µM RA from day 0 to day 1 (0-24h). This early pulse is essential for maintaining the bipotential state of Neuromesodermal Progenitors (NMPs), enabling subsequent neural tube formation [36].
• RA Withdrawal: Culture the gastruloids in standard induction medium from day 1 to day 2 (24-48h) without RA.
• Matrigel Supplementation: At day 2 (48h), embed the gastruloids in Matrigel (approximately 10%) to support advanced morphogenesis [36].
• Extended Culture: Culture the gastruloids for up to 5 days (120h total). Under these optimized conditions, 89% of elongated gastruloids robustly develop both segmented somites and a neural tube-like structure [36].

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key reagents and resources for gastruloid and embryonic model research.

Reagent / Resource	Function / Specificity	Example Application	Key References
BMP4	Indces self-organized patterning; Initiates signaling cascade	Treatment of micropatterned hPSCs to induce gastruloid formation	[52] [81]
Retinoic Acid (RA)	Signaling molecule; Indces neural fates from NMPs	Generation of RA-gastruloids with neural tube and somites	[36]
CHIR99021	Small molecule agonist of WNT signaling	Pre-treatment and maintenance of WNT pathway activity	[36]
Anti-SOX17	Marker for definitive endoderm / axial mesoderm	Staining and quality control in multiplexed IF	[68] [53]
Anti-TBXT (Brachyury)	Marker for primitive streak-like cells	Identifying the primitive streak-like ring in 2D gastruloids	[68] [81]
Anti-pSMAD1/5/9	Reporter for active BMP signaling	Measuring BMP pathway activity in spatial context	[68]
Anti-FOXA2	Transcription factor for endoderm/progenitors	Characterizing definitive endoderm differentiation	[68] [36]
Microraft Arrays	Polystyrene microwell arrays for large-scale screening	Sorting and assaying fixed or living gastruloids	[52]

Gastruloids, 2D micropatterned systems, and organoids each offer unique and complementary capabilities for modeling human development and differentiation. The choice of model must be guided by the specific research question, whether it requires the high reproducibility and analytical power of 2D systems, the advanced morphogenesis of 3D RA-gastruloids, or the pre-implantation focus of blastoids. The protocols and tools detailed herein provide a foundation for the application of these powerful models in definitive endoderm differentiation research and beyond, promising to deepen our understanding of human embryogenesis and its implications for disease modeling and regenerative medicine.

Disorders of endodermal origin represent a significant class of congenital conditions affecting major organ systems, including the respiratory and gastrointestinal tracts, liver, pancreas, and thyroid. The definitive endoderm (DE), one of the three primary germ layers formed during gastrulation, gives rise to the epithelial lining of these vital structures [82] [83]. Studying these disorders in humans presents substantial challenges due to limited tissue accessibility, ethical constraints surrounding embryonic research, and species-specific differences that limit the translational relevance of animal models [53].

Recent advances in stem cell technology and bioengineering have revolutionized our ability to model human development and disease in vitro. The emergence of sophisticated three-dimensional (3D) model systems, including gastruloids and organoids, now provides unprecedented opportunities to investigate endoderm formation, organogenesis, and the pathophysiology of related congenital disorders [82] [53]. These models recapitulate key aspects of human development while offering the experimental tractability needed for mechanistic studies and therapeutic screening.

This application note explores the integration of these innovative model systems for investigating endoderm-related congenital disorders, providing detailed protocols for generating endoderm models, and highlighting their applications in disease modeling and drug development.

Model Systems for Studying Endoderm Development

Gastruloids: Modeling Early Germ Layer Specification

Gastruloids are 3D aggregates derived from pluripotent stem cells that self-organize and recapitulate aspects of embryonic development, including germ layer specification and axial patterning [13] [4]. These models provide a powerful platform for studying definitive endoderm formation during the critical gastrulation period. Mouse gastruloids have been shown to develop distinct endodermal morphotypes through a coordinated process involving E-cadherin expression dynamics and tissue flows [4]. Single-cell analyses reveal that gastruloids generate cell types representative of embryonic and extraembryonic lineages, following a developmental timeline similar to natural embryos [84].

The formation of endoderm-like regions in gastruloids occurs through a defined sequence of events: initial loss of E-cadherin contacts in parts of the aggregate creates islands of E-cadherin-expressing cells; these populations separate through tissue flow mechanisms; and finally differentiate into Sox17+/Foxa2+ endoderm populations [4]. This process occurs without a complete epithelial-to-mesenchymal transition, challenging traditional paradigms of endoderm formation [4].

Organoids: Modeling Specific Endodermal Organs

Organoids are 3D self-organizing structures that recapitulate aspects of specific organs' architecture and cellular composition. For endodermal organs, protocols have been established to generate gastric, hepatic, pancreatic, intestinal, and pulmonary organoids from human pluripotent stem cells (hPSCs), adult stem cells, or fetal tissue [82] [85]. The fidelity of these models has been extensively validated through transcriptomic comparisons with primary tissues, revealing that hPSC-derived organoids typically resemble fetal tissues, while adult stem cell-derived organoids more closely mimic adult counterparts [85].

Recent integration of single-cell transcriptomes from hundreds of endoderm-derived organoid samples has established a comprehensive Human Endoderm-Derived Organoid Cell Atlas (HEOCA), providing a valuable reference for evaluating model fidelity and identifying off-target cell types [85]. This resource encompasses nearly one million cells across diverse conditions and protocols, enabling systematic assessment of how well organoid-derived cell states reflect those in vivo.

Table 1: Endoderm-Derived Organoid Models and Their Applications

Organ/Tissue	Disease Models	Key Markers	Applications
Stomach	H. pylori infection, Enteroendocrine specification	SOX17, FOXA2	Fundic and antral stomach development [82]
Liver	Steatohepatitis, HBV/HCV infection	ALB, AFP	Metabolic disease modeling, viral infection studies [82]
Pancreas	Diabetes, Pancreatic cancer	PDX1, NKX6-1	β-cell function, regeneration studies [82]
Intestine	Inflammatory bowel disease, Colorectal cancer	CDX2, VIL1	Barrier function, host-microbe interactions [82] [85]
Lung	Respiratory infections, Fibrosis	NKX2-1, SFTPC	Airway development, pollution toxicity studies [85]

Complete Embryo Models: Integrated Development

Recent breakthroughs have enabled the generation of complete embryo models that develop through gastrulation to neurulation and early organogenesis. These models, assembled from mouse embryonic stem cells, trophoblast stem cells, and induced extraembryonic endoderm stem cells, recapitulate the development of whole natural mouse embryos up to day 8.5 post-fertilization [84]. They form headfolds with defined brain regions, a beating heart-like structure, a neural tube, somites, a gut tube, and primordial germ cells, all within an extraembryonic yolk sac that initiates blood island development [84].

These integrated models demonstrate the self-organization ability of stem cells to reconstitute mammalian development through and beyond gastrulation, providing a comprehensive system for studying how endodermal organs form in the context of the whole embryo [84]. The ability to introduce specific genetic mutations into these models enables the study of congenital disorders in a holistic developmental context.

Experimental Protocols

Protocol 1: Definitive Endoderm Differentiation from hPSCs

This protocol directs human pluripotent stem cells (hPSCs) toward definitive endoderm fate, generating precursors for downstream organoid differentiation.

Materials:

• hPSCs (feeder-free culture)
• RPMI 1640 medium
• B-27 Supplement (minus insulin)
• Activin A (100 ng/mL)
• CHIR99021 (Wnt agonist, 3 μM)
• Matrigel or Geltrex
• Accutase or EDTA for cell dissociation

Procedure:

• Preparation: Culture hPSCs in feeder-free conditions until 80-90% confluent.
• Priming: Pre-treat with 3 μM CHIR99021 in RPMI/B-27 for 24 hours to prime cells for endoderm differentiation.
• Definitive Endoderm Induction: Replace medium with RPMI/B-27 containing 100 ng/mL Activin A and 3 μM CHIR99021 for 24 hours.
• Maturation: Continue culture for 2-3 additional days in RPMI/B-27 with 100 ng/mL Activin A alone.
• Validation: Assess efficiency by flow cytometry for CXCR4 and c-KIT co-expression (>80% positive cells indicates successful differentiation) and immunostaining for SOX17 and FOXA2.

Technical Notes:

• Cell density optimization is critical; target 80-90% confluence at initiation.
• Monitor cell size changes during differentiation, as gradual diminution correlates with improved endoderm specification [23].
• For enhanced differentiation efficiency, apply moderate hypertonic pressure (15-30 mOsm above standard) to accelerate cell size reduction and promote endoderm commitment through actomyosin-dependent mechanisms [23].

Protocol 2: 3D Gastruloid Formation for Endoderm Modeling

This protocol generates mouse or human gastruloids that undergo patterning and endoderm specification.

Materials:

• Mouse or human ESCs
• N2B27 medium
• Matrigel (for embedding)
• CHIR99021 (Wnt agonist)
• Activin A
• FGF2
• U-bottom low-adhesion 96-well plates

Procedure:

• Aggregation: Dissociate ESCs to single cells and seed 300-500 cells/well in U-bottom plates in N2B27 medium.
• Pluripotency Stabilization: Culture for 48 hours in N2B27 with 20 ng/mL Activin A and 12 ng/mL FGF2 to establish post-implantation epiblast-like state.
• Polarization Induction: Pulse with 3 μM CHIR99021 for 24 hours to induce axial organization.
• Maturation: Continue culture in base medium for up to 5-7 days, allowing for spontaneous patterning.
• Analysis: Monitor emergence of E-cadherin+ poles at aggregate tips, indicative of endoderm-like regions [4].

Technical Notes:

• For human ESC gastruloids, incorporate 10 ng/mL BMP4 during polarization stage.
• Optimize aggregate size based on cell line; 300-500 cells typically optimal for mouse, 500-1000 for human.
• Time-lapse imaging can track E-cadherin dynamics and tissue flows during endoderm specification [4].

Protocol 3: Generating Endoderm Organoids from hPSCs

This protocol describes the generation of intestinal organoids from hPSC-derived definitive endoderm.

Materials:

• DE cells (from Protocol 1)
• Advanced DMEM/F12
• B-27 Supplement
• N-2 Supplement
• Growth factors: EGF, Noggin, R-spondin
• Matrigel
• Y-27632 (ROCK inhibitor)

Procedure:

• Endoderm Patterning: Pattern DE cells toward posterior fate using 500 ng/mL FGF4 and 3 μM CHIR99021 for 3 days.
• Intestinal Specification: Culture with 100 ng/mL Noggin and 1 μg/mL R-spondin for 4 days to promote intestinal commitment.
• 3D Embedding: Resuspend intestinal progenitor cells in Matrigel and plate as droplets. Overlay with intestinal medium containing EGF, Noggin, and R-spondin.
• Maturation: Culture for 14-21 days, passaging every 7-10 days by mechanical disruption and re-embedding in Matrigel.
• Characterization: Analyze for intestinal markers (CDX2, VIL1) and functional cell types (enterocytes, goblet cells, enteroendocrine cells).

Technical Notes:

• For other endodermal organs, modify patterning signals: anterior foregut (dual SMAD inhibition + FGF), hepatic (BMP+FGF), pancreatic (retinoic acid + FGF10).
• Incorporate mesenchymal cells (10-20% co-culture) to improve morphogenesis and maturation.
• Use the Human Endoderm-Derived Organoid Cell Atlas (HEOCA) as reference for quality control and cell type identification [85].

Key Signaling Pathways and Mechanisms

Mechanical Regulation of Endoderm Specification

Recent research has revealed that biophysical cues play a crucial role in endoderm specification. Cell size has been identified as a key regulator of definitive endoderm differentiation, with smaller cell sizes promoting endoderm commitment through mechanosensitive pathways [23]. During DE differentiation from hPSCs, cell size gradually decreases, and applying hypertonic pressure to accelerate this reduction enhances DE differentiation efficiency.

The mechanism involves actomyosin-dependent nuclear translocation of angiomotin (AMOT), which suppresses Yes-associated protein (YAP) activity, thereby facilitating DE differentiation [23]. This mechanical regulation operates alongside biochemical signaling pathways to control cell fate decisions during gastrulation.

Diagram 1: Mechanical regulation of endoderm specification. Cell size reduction activates actomyosin, promoting AMOT nuclear translocation and YAP suppression to enhance endoderm differentiation [23].

Molecular Control of Endoderm Morphogenesis

Endoderm formation in gastruloids involves coordinated changes in cell adhesion and transcription factor expression. E-cadherin dynamics play a central role, with the emergence of E-cadherin-rich islands that flow toward the aggregate tip and differentiate into Sox17+/Foxa2+ endoderm populations [4]. This process is regulated by Wnt, Nodal/Activin, and BMP signaling pathways, which establish positional information and promote endoderm commitment.

The gene regulatory network controlling endoderm development is highly conserved across vertebrates, with TGFβ-signaling playing a critical role in endoderm induction [83]. Key transcription factors including Sox17, Foxa2, Gata4, and Gata6 form a core regulatory circuit that drives endoderm specification and patterning.

Table 2: Key Signaling Pathways in Endoderm Specification

Pathway	Key Components	Role in Endoderm Development	Experimental Modulation
Wnt/β-catenin	CHIR99021, β-catenin	Primitive streak formation, DE specification	CHIR99021 (agonist) [4]
Nodal/Activin	Activin A, Smad2/3	DE specification, Anterior patterning	Activin A (agonist) [4]
BMP	BMP4, Smad1/5/8	Dorsal-ventral patterning, Organ commitment	BMP4 (agonist), Noggin (antagonist) [82]
FGF	FGF2, FGF4	Foregut/midgut patterning, Organ growth	FGF2, FGF4 (agonists) [82]
YAP-Hippo	YAP, AMOT, LATS1/2	Mechanical transduction, Cell fate decisions	Verteporfin (inhibitor) [23]

Disease Modeling Applications

Modeling Neurocristopathies with Endoderm Components

Neurocristopathies represent a class of disorders arising from defects in neural crest cell development, some of which involve endoderm-derived structures. Hirschsprung disease, characterized by aganglionic megacolon due to defective enteric nervous system formation, results from impaired migration of neural crest-derived cells into the endoderm-derived intestinal tract [86]. Patient-specific iPSCs have been differentiated into neural crest cells and enteric neural crest derivatives to model this disorder and identify strategies for cellular therapy [86].

Other neurocristopathies with endoderm involvement include CHARGE syndrome, which affects multiple organs including the foregut-derived structures, and familial dysautonomia, which impacts the autonomic innervation of endoderm organs [86]. The combination of neural crest and endodermal models provides a powerful platform for investigating the pathogenesis of these complex disorders.

Modeling Gastrointestinal and Metabolic Disorders

Endoderm-derived organoids have been extensively used to model monogenic and complex disorders affecting gastrointestinal and metabolic functions. Examples include:

• Cystic Fibrosis: Intestinal and pulmonary organoids from patient-derived iPSCs used to assess CFTR function and screen corrector compounds [82]
• Inflammatory Bowel Disease: Colonic organoids to study epithelial barrier function and host-microbiome interactions [82]
• Monogenic Diabetes: Pancreatic organoids to investigate β-cell dysfunction and identify therapeutic strategies [82]
• Metabolic Liver Diseases: Hepatic organoids to model steatohepatitis and drug-induced liver injury [82]

These models enable the study of disease mechanisms in a human-specific context while providing platforms for drug screening and personalized medicine approaches.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for Endoderm Modeling

Reagent Category	Specific Examples	Function	Application Notes
Extracellular Matrices	Matrigel, Geltrex, Collagen I	3D structural support, Signaling cues	Matrigel concentration (5-10%) affects morphogenesis; use growth factor reduced for defined conditions [82]
Wnt Pathway Modulators	CHIR99021, IWP2, Wnt3a	Axis patterning, DE specification	CHIR99021 concentration (1-6 μM) and pulse duration critical for gastruloid patterning [4]
TGF-β Family Ligands	Activin A, BMP4, Noggin	Germ layer specification, Patterning	Activin A concentration (50-100 ng/mL) determines endoderm efficiency [23]
Cytoskeletal Modulators	Y-27632 (ROCK inhibitor), Blebbistatin	Enhance cell survival, Modulate mechanics	Y-27632 essential for single-cell passaging; use 10 μM for 24h post-dissociation [23]
Metabolic Regulators	Sodium pyruvate, B-27, N-2	Support specific cell types	B-27 minus insulin favors DE; with insulin supports later stages [23]

The integration of gastruloid and organoid technologies has transformed our ability to model human endoderm development and related congenital disorders. These 3D model systems recapitulate key aspects of in vivo development while offering unprecedented experimental accessibility. The combination of biochemical signaling, mechanical cues, and emerging bioengineering approaches provides a powerful framework for investigating disease mechanisms and developing therapeutic strategies.

As these technologies continue to evolve, efforts to standardize protocols, validate model fidelity through comprehensive atlasing, and integrate multiple cell types will further enhance their utility. The application of these models to endoderm-related congenital disorders holds particular promise for understanding pathogenesis and advancing personalized medicine approaches for these conditions.

The pharmaceutical development pipeline faces a significant challenge in accurately predicting compound toxicity during early human development. Traditional animal models exhibit critical inter-species differences that limit their predictive value for human teratogenicity, as tragically demonstrated by the thalidomide crisis [87]. Furthermore, conventional in vitro models, such as adherent monolayer cultures or disorganized 3D structures, lack the spatiotemporal and morphological context of the developing embryo, limiting their physiological relevance [87]. Within this context, definitive endoderm (DE) gastruloids have emerged as a powerful, human-relevant platform for toxicology and screening. Gastruloids are three-dimensional aggregates of pluripotent stem cells that recapitulate key events of gastrulation, including symmetry breaking, axial elongation, and differentiation into the three germ layers—mesoderm, ectoderm, and endoderm [87] [4]. Unlike other models, gastruloids provide a robust recapitulation of gastrulation-like events alongside morphological coordination at a relatively high throughput, making them exceptionally suited for developmental toxicity assessment [87].

This Application Note details the methodology and application of endoderm-containing gastruloids for pharmaceutical screening. It provides a comprehensive protocol for generating robust DE gastruloids, outlines key analytical endpoints for teratogenicity assessment, and presents a structured framework for data interpretation. By implementing this platform, researchers can contribute to the 3Rs principles (Replace, Reduce, Refine animal use) while achieving human-specific predictions earlier in the drug development pipeline [87] [88].

Theoretical Background: Endoderm Development in Gastruloids

The Role of Definitive Endoderm in Development and Toxicity

The definitive endoderm is one of the three primary germ layers formed during gastrulation. It gives rise to the epithelial lining of the respiratory and digestive tracts, as well as associated organs including the liver, pancreas, and thymus [89] [23]. Consequently, disruptive events during endoderm specification and morphogenesis can lead to severe congenital abnormalities. The in vitro differentiation of DE from pluripotent stem cells mirrors in vivo development, progressing through a primitive streak-like state characterized by the upregulation of T/Brachyury (T-Bra) and MIXL1, followed by the robust expression of DE markers including SOX17, FOXA2, and GATA4 [89] [4].

Morphogenesis and Variability in Gastruloid Models

In gastruloids, definitive endoderm develops in distinct morphotypes, a process that requires precise coordination between endoderm progression and gastruloid elongation [13] [9]. Recent studies have cataloged these different morphologies and characterized their statistics, identifying that a fragile coordination exists between the endoderm and the underlying mesoderm, which drives axial elongation [9] [4]. Disruption of this coordination can lead to failed endodermal progression and increased morphological variability [9]. The formation of an endoderm-like region in mouse gastruloids has been shown to occur via a three-step mechanism: (i) localized loss of E-cadherin mediated contacts creating islands of E-cadherin-expressing cells, (ii) a flow of these epithelial islands toward the aggregate tip, and (iii) their differentiation into SOX17+/FOXA2+ endoderm [4]. This process occurs without a complete epithelial-to-mesenchymal transition (EMT), challenging traditional models and highlighting the unique insights possible with the gastruloid system [4].

Experimental Protocol: Generating Robust Endoderm Gastruloids

The following diagram illustrates the complete workflow for generating and analyzing endoderm gastruloids for toxicology screening, integrating critical steps from cell preparation through to final assessment.

Detailed Materials and Reagents

Table 1: Essential Research Reagent Solutions for Endoderm Gastruloid Generation

Reagent Category	Specific Examples	Function in Protocol	Key Considerations
Basal Medium	N2B27, RPMI/B27	Chemically defined base medium supporting differentiation	Insulin-free B27 may enhance DE yield; batch consistency is critical [89]
WNT Agonist	CHIR99021 (3-4 µM)	GSK3β inhibitor inducing primitive streak-like state	Concentration must be optimized per cell line [89] [23]
Nodal/TGF-β Activator	Activin A	Promotes endodermal differentiation from primitive streak
Retinoid	Retinoic Acid (100 nM-1 µM)	Promotes neural tube formation & posterior patterning; critical for human gastruloids [36]	Early pulse (0-24h) is essential; discontinuous regimen optimal [36]
Extracellular Matrix	Matrigel	Supports 3D organization, elongation, and somite segmentation [36]	Added after 48h; concentration affects structure maturity
Cell Lines	Mouse E14Tg2A, T/Bra::GFP; Human RUES2-GLR (mCit-SOX2, mCer-BRA, tdTom-SOX17)	Reporter lines enable live imaging of lineage specification [87] [36]	Species-specific responses to teratogens can be assessed [87]

Step-by-Step Procedures

Pre-culture and Cell Preparation

• Maintain pluripotent stem cells in a naive state using 2i/LIF medium or primed state using serum-containing media on gelatin-coated plates. The choice of pre-culture conditions significantly affects differentiation propensity and requires optimization [9].
• Passage cells at least twice post-thawing before gastruloid generation, but do not exceed 30 passages in vitro to maintain genetic stability [87].
• Pre-treat cells with 2i/LIF medium for 24 hours prior to gastruloid generation to synchronize cell states [87].

Gastruloid Aggregation and Differentiation

• Harvest cells to a single-cell suspension using appropriate dissociation reagents (e.g., Trypsin-EDTA, Accutase).
• Count cells and resuspend in N2B27 medium at a concentration appropriate for the aggregation method.
• Transfer 40 µL droplets containing 300-500 cells per well into U-bottom 96-well plates (low-adhesion). For human gastruloids, some protocols may require higher initial cell numbers [36].
• Centrifuge plates briefly (500 rpm for 2 minutes) to ensure all cells gather at the bottom of the well, promoting uniform aggregate formation.
• Culture aggregates for 48 hours in N2B27 medium to allow symmetry breaking and initial patterning.
• Add CHIR99021 (3-4 µM in N2B27) for 24-48 hours to induce primitive streak formation and initiate axial elongation [87] [89].
• Implement retinoic acid pulse (100 nM-1 µM) from 0-24 hours for human gastruloids to promote bipotentiality of neuromesodermal progenitors and enable subsequent neural tube and somite formation [36].
• Add Matrigel (approximately 10% v/v) at 48 hours to support further elongation and morphological patterning [36].

Compound Exposure and Teratogenicity Testing

• Add test compounds at the initiation of differentiation (0 hours) and daily thereafter (at 48h, 72h, and 96h post-plating) to assess effects across different developmental windows [87].
• Include reference teratogens as positive controls (e.g., all-trans retinoic acid, valproic acid, bosentan, thalidomide, phenytoin) and non-teratogens as negative controls (e.g., penicillin G) [87].
• Use a range of concentrations (typically 3-5 log dilutions) to determine dose-response relationships and calculate IC50 values where applicable.

Data Analysis and Endpoints for Teratogenicity Assessment

Key Analytical Parameters

Comprehensive assessment of teratogenic effects in endoderm gastruloids requires multi-parameter analysis. The following table summarizes the primary quantitative endpoints for reliable teratogenicity assessment.

Table 2: Key Analytical Endpoints for Teratogenicity Assessment in Endoderm Gastruloids

Parameter Category	Specific Measurable Endpoints	Detection Method	Significance in Toxicity Assessment
Gross Morphology	Degree of elongation (aspect ratio), size (projected area), presence of somites/neural tube	Brightfield imaging, automated image analysis	Significant reduction in elongation or decreased size indicates disrupted axial patterning [87] [36]
Cell Viability & Proliferation	Cell viability, apoptosis (Caspase-3/7), proliferation (Ki-67, BrdU)	Fluorescence assays, immunohistochemistry	Cytotoxicity and reduced proliferation indicate general developmental toxicity [87] [9]
Lineage Specification	SOX17+ (endoderm), BRA/T+ (mesoderm), SOX2+ (neuroectoderm) proportions and spatial organization	Fluorescent reporters, immunostaining, scRNA-seq	Aberrant gene expression suggests multi-lineage differentiation defects; altered proportions indicate specific teratogenic effects [87] [36]
Gene Expression	Transcript levels of SOX17, FOXA2, BRA, SOX2, CER1, MIXL1	qRT-PCR, scRNA-seq, spatial transcriptomics	Disrupted axial patterning and lineage specification at molecular level [87] [89]
Advanced Morphogenesis	Presence of segmented somites, neural tube, gut tube structures	3D confocal imaging, immunohistochemistry	Failure to form organized structures indicates severe morphogenetic disruption [36] [4]

Signaling Pathways Governing Endoderm Specification

The differentiation of definitive endoderm in gastruloids is regulated by an interplay of key signaling pathways. The following diagram illustrates the major pathways and their interactions in this process.

Protocol Optimization and Troubleshooting

Managing Gastruloid Variability

Gastruloids, like most organoid systems, can display significant variability that must be controlled for robust screening applications. Key strategies include:

• Standardize pre-growth conditions: Use defined media components to minimize batch-to-batch variability and carefully control cell passage number [9].
• Optimize initial cell count: Utilize microwell arrays or hanging drops for highly uniform aggregate formation. Increasing initial cell number can reduce sampling bias [9].
• Implement quality control checkpoints: Use early morphological parameters (e.g., aggregate size at 24-48 hours) to exclude outliers before compound exposure [9].
• Apply machine learning approaches: Train predictive models using early morphological and expression parameters to identify gastruloids likely to deviate from normal development [13] [9].

Enhancing Endoderm Formation

• Modulate WNT signaling: For cell lines with poor endoderm representation, extend the CHIR99021 pulse or combine with Activin A treatment [9] [89].
• Apply hypertonic pressure: Recent evidence indicates that cell size reduction enhances DE differentiation through actomyosin-dependent nuclear translocation of angiomotin (AMOT) and subsequent suppression of YAP activity [23]. Moderate hypertonic pressure can be applied to promote this differentiation-enhancing mechanism.
• Optimize retinoic acid timing: For human gastruloids, an early pulse (0-24 hours) is critical for establishing bipotential neuromesodermal progenitors that subsequently contribute to posterior neural tube and somite formation [36].

Application in Pharmaceutical Development

The endoderm gastruloid platform enables medium-throughput screening of compound libraries for developmental toxicity. The system has demonstrated capability to:

• Recapitulate species-specific sensitivities: Mouse and human gastruloids exhibit differential responses to known teratogens, mirroring species-specific susceptibilities observed in vivo [87].
• Identify mechanistic insights: Combined with single-cell RNA sequencing, the platform can reveal disrupted signaling pathways and lineage specification decisions underlying teratogenic effects [36] [90].
• Provide quantitative dose-response data: Concentration-dependent effects on morphology and gene expression enable calculation of IC50 values and determination of safety margins [87].

This platform represents a significant advance in human-relevant developmental toxicity assessment, offering a physiologically complex yet scalable system that bridges the gap between traditional in vitro models and in vivo studies. Through implementation of these protocols, pharmaceutical developers can enhance the detection of teratogenic liabilities earlier in the drug discovery process, ultimately contributing to safer medicines for women of childbearing potential.

Conclusion

The gastruloid system has emerged as a powerful and scalable platform for studying definitive endoderm specification, offering unprecedented insights into early human development. By integrating foundational knowledge of cellular mechanisms with optimized protocols that address inherent variability, researchers can now generate more robust and reproducible endoderm models. Key advances, such as retinoic acid pulsing and the modulation of biophysical forces like cell size, have significantly enhanced the fidelity of these in vitro systems. Looking forward, the continued refinement of gastruloid protocols, particularly through the integration of extra-embryonic cell types and advanced engineering tools, promises to unlock even more complex aspects of morphogenesis. This progress solidifies the position of gastruloids as an indispensable tool for decoding human embryogenesis, modeling congenital diseases, and advancing drug discovery pipelines for endoderm-derived tissues.

References

• 1. The endoderm: a divergent cell lineage with many ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6589075/]
• 2. Endoderm [https://en.wikipedia.org/wiki/Endoderm]
• 3. 3D gastruloids: a novel frontier in stem cell-based in vitro ... [https://www.sciencedirect.com/science/article/pii/S0962892421001239]
• 4. Cell-state transitions and collective cell movement ... [https://elifesciences.org/articles/59371]
• 5. A Molecular Signature for Purified Definitive Endoderm ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3411363/]
• 6. Protocol for differentiation of human pluripotent stem cells into ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12205342/]
• 7. Culture Systems & Reagents for Definitive Endoderm ... [https://www.thermofisher.com/us/en/home/life-science/stem-cell-research/stem-cell-differentiation/culture-systems-reagents-for-definitive-endoderm-differentiation.html]
• 8. Endoderm - Embryology [https://embryology.med.unsw.edu.au/embryology/index.php/Endoderm]
• 9. Gastruloid optimization - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10754328/]
• 10. STEMdiff™ Definitive Endoderm Differentiation Kit [https://www.stemcell.com/products/stemdiff-definitive-endoderm-kit.html]
• 11. Metabolic and Epigenetic Regulation of Endoderm ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8760149/]
• 12. Potential role of Sigma-1 receptor inhibition and ER stress ... [https://www.sciencedirect.com/science/article/abs/pii/S0014482725001533]
• 13. Coordination between endoderm progression and mouse ... [https://www.sciencedirect.com/science/article/pii/S1534580724003356]
• 14. A gastruloid model of the interaction between embryonic and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9189523/]
• 15. Long noncoding RNA as an emerging regulator of endoderm ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11937447/]
• 16. Identification of an embryonic differentiation stage marked ... [https://www.nature.com/articles/s41467-024-52069-z]
• 17. Single-cell RNA-seq reveals novel regulators of human ... [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-1033-x]
• 18. Epithelial cell plasticity drives endoderm formation during ... [https://www.nature.com/articles/s41556-021-00694-x]
• 19. E-cadherin negatively regulates hESCs endodermal ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12185850/]
• 20. Observation of E-cadherin adherens junction dynamics ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11606943/]
• 21. Generation of enhanced definitive endoderm from human ... [https://www.sciencedirect.com/science/article/abs/pii/S0024320517301005]
• 22. Defined three-dimensional culture conditions mediate efficient ... [https://stemcellres.biomedcentral.com/articles/10.1186/s13287-016-0426-9]
• 23. Cell size regulates human endoderm specification through ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11368700/]
• 24. Frontiers | Differentiation of Human Pluripotent Stem Cells Into Definitive Endoderm Cells in Various Flexible Three-Dimensional Cell Culture Systems: Possibilities and Limitations [https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.726499/full]
• 25. Efficient differentiation of human embryonic stem cells to definitive endoderm - PubMed [https://pubmed.ncbi.nlm.nih.gov/16258519/]
• 26. Efficient Generation of Induced Pluripotent Stem Cell-Derived Definitive Endoderm Cells with Growth Factors and Small Molecules [https://www.mdpi.com/2073-4409/14/11/815]
• 27. Regulation of endodermal differentiation of human ... [https://asu.elsevierpure.com/en/publications/regulation-of-endodermal-differentiation-of-human-embryonic-stem-/]
• 28. The role of activin/nodal and Wnt signaling in endoderm ... [https://pubmed.ncbi.nlm.nih.gov/21353882/]
• 29. Article FGFR-mediated ERK1/2 signaling contributes to ... [https://www.sciencedirect.com/science/article/pii/S2589004223013421]
• 30. Wnt signaling specifies and patterns intestinal endoderm [https://www.sciencedirect.com/science/article/pii/S092547731100092X]
• 31. Optimizing Nodal, Wnt and BMP signaling pathways for robust ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11182123/]
• 32. Bmp signaling is necessary and sufficient for ventrolateral ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4497515/]
• 33. Advances in engineered models of peri-gastrulation [https://www.sciencedirect.com/science/article/pii/S2589004225009204]
• 34. Chemically defined and growth factor-free system for highly ... [https://www.sciencedirect.com/science/article/pii/S2213671124003266]
• 35. Development of a quantitative prediction algorithm for ... [https://www.nature.com/articles/s41467-021-24746-w]
• 36. Retinoic acid induces human gastruloids with posterior ... [https://www.nature.com/articles/s41556-024-01487-8]
• 37. Retinoic Acid Fluctuation Activates an Uneven, Direction ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8564372/]
• 38. Modulation of All-Trans Retinoic Acid by Light and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11927300/]
• 39. Hypertonic pressure affects the pluripotency and self ... [https://pubmed.ncbi.nlm.nih.gov/34562798/]
• 40. In silico discovery of small molecules for efficient stem cell ... [https://www.sciencedirect.com/science/article/pii/S2213671123000115]
• 41. An Optimized Protocol for the Extended Culture of ... [https://pubmed.ncbi.nlm.nih.gov/40973928/]
• 42. The microplate: utility in practice [https://www.bmglabtech.com/en/the-microplate-utility-in-practice/]
• 43. Assembly and Tracking of Microbial Community ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5608264/]
• 44. Orbitally Shaken Bioreactors - Easy Scale up [https://kuhner.com/en/kuhner-technology/scale-up.php]
• 45. Microplate Selection and Recommended Practices in High ... [https://www.ncbi.nlm.nih.gov/books/NBK558077/]
• 46. Matrigel inhibits elongation and drives endoderm ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12319711/]
• 47. Matrigel Matrix | Trusted Extracellular Matrices [https://www.corning.com/worldwide/en/products/life-sciences/products/surfaces/matrigel-matrix.html]
• 48. Generating human intestinal tissue from pluripotent stem ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3896236/]
• 49. Generating human intestinal tissues from pluripotent stem ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4426477/]
• 50. Regulation of endodermal differentiation of human ... [https://www.nature.com/articles/cdd2012138]
• 51. Generating Human Tissues from Pluripotent Stem Cells [https://www.cincinnatichildrens.org/research/divisions/d/dev-biology/labs/wells/generating-human-tissues-from-pluripotent-stem-cells]
• 52. Development of large-scale gastruloid array to identify ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12158465/]
• 53. Advances in engineered models of peri-gastrulation - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC12159512/]
• 54. A high-content small molecule screen identifies novel ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5485240/]
• 55. Automated optimization of endoderm differentiation on chip [https://pubs.rsc.org/en/content/articlehtml/2021/lc/d1lc00565k]
• 56. Definitive Endoderm Differentiation of BG01V Human ... [https://www.rndsystems.com/resources/protocols/definitive-endoderm-differentiation-bg01v-human-embryonic-stem-cells]
• 57. Control of gastruloid patterning and morphogenesis by the Erk ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11106667/]
• 58. Stem cell culture conditions affect in vitro differentiation ... [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0317309]
• 59. Gastruloid Development Competence Discriminates Different ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7878839/]
• 60. Comparative analysis of naive, primed and ground state pluripotency in mouse embryonic stem cells originating from the same genetic background | Scientific Reports [https://www.nature.com/articles/s41598-018-24051-5]
• 61. Predicting differentiation potential of human pluripotent ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6682503/]
• 62. 4.16. Definitive Endoderm Differentiation [https://bio-protocol.org/exchange/minidetail?id=8186082&type=30]
• 63. Regulation of lymphoid-myeloid lineage bias through ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10808253/]
• 64. Leukemic stem cells activate lineage inappropriate ... [https://www.nature.com/articles/s41467-024-45691-4]
• 65. Position- and Hippo signaling-dependent plasticity during ... [https://elifesciences.org/articles/22906]
• 66. Differentiation of Human Pluripotent Stem Cells Into ... [https://pubmed.ncbi.nlm.nih.gov/34568336/]
• 67. Deep Learning Powered Identification of Differentiated ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10969030/]
• 68. Spatial Single Cell Analysis of Proteins in 2D Human ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11132115/]
• 69. A live-cell image-based machine learning strategy for ... [https://www.nature.com/articles/s41421-023-00543-1]
• 70. A quantitative pipeline for whole-mount deep imaging and ... [https://elifesciences.org/reviewed-preprints/107154]
• 71. Transcriptional benchmarking of in vitro cells to in vivo with ... [https://www.rna-seqblog.com/transcriptional-benchmarking-of-in-vitro-cells-to-in-vivo-with-single-cell-rna-seq/]
• 72. Applications of single-cell RNA sequencing in drug discovery ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10141847/]
• 73. Benchmarking single-cell RNA-sequencing protocols for ... [https://www.nature.com/articles/s41587-020-0469-4]
• 74. Benchmarking single-cell RNA-sequencing protocols for cell ... [https://pubmed.ncbi.nlm.nih.gov/32518403/]
• 75. Benchmarking metabolic RNA labeling techniques for high ... [https://www.nature.com/articles/s41467-025-61375-z]
• 76. Single-cell RNA-seq reveals novel regulators of ... - PubMed [https://pubmed.ncbi.nlm.nih.gov/27534536/]
• 77. A dataset of definitive endoderm and hepatocyte ... [https://www.nature.com/articles/s41597-023-02001-9]
• 78. A perfect islet: reviewing recent protocol developments and ... [https://stemcellres.biomedcentral.com/articles/10.1186/s13287-025-04293-7]
• 79. Analysis of Differentiation Protocols Defines a Common ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6962645/]
• 80. Transdifferentiation of pancreatic progenitor cells to ... [https://www.nature.com/articles/s41598-018-22596-z]
• 81. Extended culture of 2D gastruloids to model human ... - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10996563/]
• 82. Modeling endodermal organ development and diseases ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7683020/]
• 83. Modeling endoderm development and disease in Xenopus [https://pubmed.ncbi.nlm.nih.gov/34074536/]
• 84. Embryo model completes gastrulation to neurulation and ... [https://www.nature.com/articles/s41586-022-05246-3]
• 85. An integrated transcriptomic cell atlas of human endoderm- ... [https://www.nature.com/articles/s41588-025-02182-6]
• 86. Modeling human congenital disorders with neural crest ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8390449/]
• 87. In vitro teratogenicity testing using a 3D, embryo-like ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8522962/]
• 88. The Path towards Humanized 3D Stem Cell-Based Models [https://pmc.ncbi.nlm.nih.gov/articles/PMC10002991/]
• 89. Development of a rapid screen for the endodermal ... [https://www.nature.com/articles/srep37178]
• 90. Advanced human developmental toxicity and teratogenicity ... [https://www.sciencedirect.com/science/article/pii/S014765132200269X]